RxNorm Semantic Concepts Index - 137
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "137".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 1370000 | Lactobacillus acidophilus 10000000000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1370001 | Lactobacillus acidophilus 10 Billion UNT Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1370001 | Lactobacillus acidophilus 10 Billion UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370001 | Lactobacillus acidophilus 10 Billion UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1370002 | methscopolamine nitrate 2.5 MG / phenylephrine HCl 40 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1370002 | methscopolamine nitrate 2.5 MG / phenylephrine HCl 40 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1370003 | methscopolamine nitrate 2.5 MG / phenylephrine hydrochloride 40 MG [AlleRx PE AM] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1370004 | AlleRx PE AM 2.5 MG / 40 MG 12HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1370004 | AlleRx PE AM 2.5 MG / 40 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370004 | AlleRx PE AM 2.5 MG / 40 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1370005 | methscopolamine nitrate 2.5 MG / phenylephrine hydrochloride 40 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1370006 | methscopolamine nitrate 2.5 MG / phenylephrine hydrochloride 40 MG Extended Release Oral Tablet [AlleRx PE AM] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370006 | methscopolamine nitrate 2.5 MG / phenylephrine hydrochloride 40 MG Extended Release Oral Tablet [AlleRx PE AM] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1370014 | {30 (12 HR chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG / phenylephrine hydrochloride 10 MG Extended Release Oral Tablet) / 30 (12 HR methscopolamine nitrate 2.5 MG / phenylephrine hydrochloride 40 MG Extended Release Oral Tablet) } Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1370025 | pyrilamine maleate 1.66 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1370026 | APAP 21.7 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / Pseudoephedrine Hydrochloride 2 MG/ML / Pyrilamine Maleate 1.66 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1370026 | APAP 21.7 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / Pseudoephedrine Hydrochloride 2 MG/ML / Pyrilamine Maleate 1.66 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370026 | APAP 21.7 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / Pseudoephedrine Hydrochloride 2 MG/ML / Pyrilamine Maleate 1.66 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370093 | resorcinol 0.2 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1370094 | sulfur 0.3 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1370095 | resorcinol / sulfur Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1370096 | resorcinol / sulfur Paste | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1370097 | resorcinol 20 % / sulfur 30 % Topical Paste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1370097 | resorcinol 20 % / sulfur 30 % Topical Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370097 | resorcinol 20 % / sulfur 30 % Topical Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1370097 | resorcinol 20 % / sulfur 30 % Topical Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370098 | triclosan 4.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1370099 | triclosan 0.45 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1370099 | triclosan 0.45 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370099 | triclosan 0.45 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1370104 | Freesia alba flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370105 | Waltheria indica leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370107 | dibutyl ethylhexanoyl glutamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370108 | dibutyl lauroyl glutamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370109 | Vaccinium myrtillus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370110 | zinc acetylmethionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370113 | acetaminophen 160 MG / dextromethorphan HBr 5 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1370113 | acetaminophen 160 MG / dextromethorphan HBr 5 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370113 | acetaminophen 160 MG / dextromethorphan HBr 5 MG in 5 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1370113 | acetaminophen 160 MG / dextromethorphan HBr 5 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370113 | acetaminophen 160 MG / dextromethorphan HBr 5 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370116 | APAP 500 MG / chlorpheniramine maleate 4 MG / dextromethorphan hydrobromide 20 MG / pseudoephedrine hydrochloride 60 MG per 15 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1370116 | APAP 500 MG / chlorpheniramine maleate 4 MG / dextromethorphan hydrobromide 20 MG / pseudoephedrine hydrochloride 60 MG per 15 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370116 | APAP 500 MG / chlorpheniramine maleate 4 MG / dextromethorphan hydrobromide 20 MG / pseudoephedrine hydrochloride 60 MG per 15 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370119 | APAP 500 MG / dextromethorphan hydrobromide 20 MG / pseudoephedrine hydrochloride 60 MG per 15 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1370119 | APAP 500 MG / dextromethorphan hydrobromide 20 MG / pseudoephedrine hydrochloride 60 MG per 15 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370119 | APAP 500 MG / dextromethorphan hydrobromide 20 MG / pseudoephedrine hydrochloride 60 MG per 15 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370122 | chlorpheniramine maleate 0.2 MG/mL / dextromethorphan hydrobromide 1 MG/mL / phenylephrine hydrochloride 0.5 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1370122 | chlorpheniramine maleate 0.2 MG/mL / dextromethorphan hydrobromide 1 MG/mL / phenylephrine hydrochloride 0.5 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1370122 | chlorpheniramine maleate 0.2 MG/mL / dextromethorphan hydrobromide 1 MG/mL / phenylephrine hydrochloride 0.5 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370125 | chlorpheniramine maleate 2 MG / dextromethorphan HBr 15 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1370125 | chlorpheniramine maleate 2 MG / dextromethorphan HBr 15 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1370125 | chlorpheniramine maleate 2 MG / dextromethorphan HBr 15 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370191 | Acacia angustissima bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370192 | polyethylene glycol 4000000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370193 | propylene glycol 1,2-distearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370194 | Salvia officinalis flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370195 | sodium C18 olefin sulfonate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1370196 | C18 olefin sulfonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370197 | Sorghum bicolor whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370199 | {10 (12 HR chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG / phenylephrine hydrochloride 10 MG Extended Release Oral Tablet) / 10 (12 HR methscopolamine nitrate 2.5 MG / phenylephrine hydrochloride 40 MG Extended Release Oral Tablet) } Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1370201 | {1 (12 HR chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG / phenylephrine hydrochloride 10 MG Extended Release Oral Tablet) / 1 (12 HR methscopolamine nitrate 2.5 MG / phenylephrine hydrochloride 40 MG Extended Release Oral Tablet) } Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1370205 | dextromethorphan HBr 5 MG / guaiFENesin 50 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1370205 | dextromethorphan HBr 5 MG / guaiFENesin 50 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1370205 | dextromethorphan HBr 5 MG / guaiFENesin 50 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1370205 | dextromethorphan HBr 5 MG / guaiFENesin 50 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370205 | dextromethorphan HBr 5 MG / guaiFENesin 50 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1370205 | dextromethorphan HBr 5 MG / guaiFENesin 50 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370205 | dextromethorphan HBr 5 MG / guaiFENesin 50 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1370211 | dextromethorphan HBr 7.5 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1370211 | dextromethorphan HBr 7.5 MG in 5 mL Oral Solution | Designated preferred name (PT) | YES | |
| RxCUI: 1370211 | dextromethorphan HBr 7.5 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1370211 | dextromethorphan HBr 7.5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370211 | dextromethorphan HBr 7.5 MG in 5 mL Oral Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 1370216 | dextromethorphan HBr 10 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1370216 | dextromethorphan HBr 10 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370216 | dextromethorphan HBr 10 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1370219 | dextromethorphan HBr 5 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1370219 | dextromethorphan HBr 5 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1370222 | dextromethorphan hydrobromide 6 MG/ML / guaifenesin 40 MG/ML / pseudoephedrine hydrochloride 2 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1370222 | dextromethorphan hydrobromide 6 MG/ML / guaifenesin 40 MG/ML / pseudoephedrine hydrochloride 2 MG/ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1370284 | caffeine 1.08 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1370285 | acetaminophen 1000 MG / caffeine 65 MG in 60 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1370285 | acetaminophen 1000 MG / caffeine 65 MG in 60 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1370285 | acetaminophen 1000 MG / caffeine 65 MG in 60 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370292 | benzoyl peroxide 2.5 % Medicated Liquid Soap (118 ML) / benzoyl peroxide 2.5 % Topical Lotion (118 ML) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370292 | benzoyl peroxide 2.5 % Medicated Liquid Soap (118 ML) / benzoyl peroxide 2.5 % Topical Lotion (118 ML) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1370292 | benzoyl peroxide 2.5 % Medicated Liquid Soap (118 ML) / benzoyl peroxide 2.5 % Topical Lotion (118 ML) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1370293 | Killitch | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1370294 | benzyl benzoate 250 MG/ML [Killitch] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1370295 | benzyl benzoate Topical Lotion [Killitch] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1370296 | Killitch Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1370297 | Killitch 25 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1370297 | Killitch 25 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1370297 | Killitch 25 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370297 | Killitch 25 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370298 | Antiaris toxicara resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370299 | ferrous arsenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370301 | Rubia tinctorum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370302 | Bitter almond oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370302 | Bitter almond oil | Designated preferred name (PT) | NO | |
| RxCUI: 1370302 | Bitter almond oil | Full form of descriptor (FN) | NO | |
| RxCUI: 1370303 | sucrose distearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370365 | Ceftiflex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1370366 | ceftiofur 50 MG/ML [Ceftiflex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1370367 | ceftiofur Injectable Suspension [Ceftiflex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1370368 | Ceftiflex Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1370369 | Ceftiflex 50 MG/ML Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1370369 | Ceftiflex 50 MG/ML Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370369 | Ceftiflex 50 MG/ML Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1370370 | hydrogen peroxide 12.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1370371 | hydrogen peroxide 1.25 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1370371 | hydrogen peroxide 1.25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370371 | hydrogen peroxide 1.25 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1370372 | Ceftiofur sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1370372 | Ceftiofur sodium | Designated preferred name (PT) | YES | |
| RxCUI: 1370372 | Ceftiofur sodium | Full form of descriptor (FN) | YES | |
| RxCUI: 1370373 | brine shrimp extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370418 | tricaine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370419 | transforming growth factor beta 2 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370420 | calcium borogluconate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1370421 | borogluconate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370422 | potash | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370423 | trilaureth-4 phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370424 | tetradecyl hydrogen sulfate (ester) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370425 | aluminum zirconium trichlorohydrex gly | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370427 | guaiFENesin 200 MG / phenylephrine hydrochloride 5 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1370427 | guaiFENesin 200 MG / phenylephrine hydrochloride 5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370427 | guaiFENesin 200 MG / phenylephrine hydrochloride 5 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1370427 | guaiFENesin 200 MG / phenylephrine hydrochloride 5 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1370427 | guaiFENesin 200 MG / phenylephrine hydrochloride 5 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1370435 | licorice extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370435 | licorice extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370439 | microspheres of human albumin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370439 | microspheres of human albumin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370440 | acetaminophen 250 MG / chlorpheniramine maleate 4 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1370440 | acetaminophen 250 MG / chlorpheniramine maleate 4 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370440 | acetaminophen 250 MG / chlorpheniramine maleate 4 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1370440 | acetaminophen 250 MG / chlorpheniramine maleate 4 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370450 | acetic anhydride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370451 | alginate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370452 | amyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370453 | zinc oxide 0.206 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1370454 | zinc oxide 20.6 % / menthol 0.5 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1370454 | zinc oxide 20.6 % / menthol 0.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370454 | zinc oxide 20.6 % / menthol 0.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370454 | zinc oxide 20.6 % / menthol 0.5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1370457 | methyl salicylate 0.101 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1370458 | camphor 3.1 % / menthol 2.6 % / methyl salicylate 10.1 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1370458 | camphor 3.1 % / menthol 2.6 % / methyl salicylate 10.1 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1370458 | camphor 3.1 % / menthol 2.6 % / methyl salicylate 10.1 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370459 | ascorbic acid 2-sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1370460 | ascorbate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370461 | cholesteryl hydroxystearate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1370462 | hydroxystearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370464 | beef lung preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370465 | bovine nasal mucosa preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370465 | bovine nasal mucosa preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370466 | Juglans nigra whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370467 | fennel extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370468 | fluke, unspecified preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370469 | onion extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370470 | clary sage extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370474 | metoprolol succinate 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1370476 | hydrochlorothiazide 12.5 MG / metoprolol succinate 50 MG [Dutoprol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1370476 | hydrochlorothiazide 12.5 MG / metoprolol succinate 50 MG [Dutoprol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1370483 | metoprolol succinate 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1370485 | metoprolol succinate 100 MG [Toprol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1370489 | metoprolol succinate 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1370491 | hydrochlorothiazide 12.5 MG / metoprolol succinate 25 MG [Dutoprol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1370491 | hydrochlorothiazide 12.5 MG / metoprolol succinate 25 MG [Dutoprol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1370496 | hydrochlorothiazide 12.5 MG / metoprolol succinate 100 MG [Dutoprol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1370496 | hydrochlorothiazide 12.5 MG / metoprolol succinate 100 MG [Dutoprol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1370500 | metoprolol succinate 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1370502 | metoprolol succinate 200 MG [Toprol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1370507 | metoprolol succinate 25 MG [Toprol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1370512 | metoprolol succinate 50 MG [Toprol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1370569 | dimercaptosuccinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370570 | laidlomycin propionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370571 | lauroamphoacetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370572 | 3-hydroxy-4-methoxybenzenesulfonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370573 | butedronate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370574 | valerate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370575 | polyacrylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370578 | stearalkonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370579 | behentrimonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370580 | lauroyl aspartate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370581 | 2-sulfolaurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370583 | dodecahydroxycyclohexane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370584 | myristoyl glutamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370585 | palmitoyl glutamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370586 | glycyrrhizate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370587 | myristalkonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370589 | polacrillin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370590 | dihydroxypropyltrimonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370591 | methyl aminomethylcyclohexane carboxamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370592 | lauroyl lactylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370593 | carnosine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1370594 | laurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370595 | starch glycolate type a corn | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370596 | C14-16 olefin sulfonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370597 | myristoyl sarcosinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370598 | cocoyl sarcosinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370599 | ricinoleic monoethanolamide sulfosuccinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370600 | Ethylenediaminetetraacetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370600 | Ethylenediaminetetraacetate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370601 | xylenesulfonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370602 | caproamphodipropionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370603 | ethylene dicocamide peg-15 disulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370604 | sulfosalicylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370605 | ascorbyl phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370606 | C12-15 pareth-3 sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370607 | diethyl oxalacetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370608 | lauroyl isethionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370609 | methyl 2-sulfolaurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370610 | methyl cocoyl taurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370611 | sarcosinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370612 | ethylenediamine disuccinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370614 | lauroyl glutamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370615 | bis(1-methylamyl) sulfosuccinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370616 | isostearoyl lactylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370617 | laureth-2 sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370618 | lauroyl sarcosinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370619 | myristoyl isethionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370620 | palm kernelate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370621 | palmitate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370622 | palmitoyl proline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370623 | pyrrolidone carboxylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370624 | starch glycolate type b potato | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370625 | stearoyl glutamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370626 | stearyl fumarate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370627 | thioglycolate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370628 | cetostearyl sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370629 | manganese acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370630 | azeloyl diglycinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370631 | cocoyl glutamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370634 | cumenesulfonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370635 | dehydroacetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370636 | starch glycolate type a potato | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370637 | starch glycolate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370638 | oleanolate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370639 | lauryl sarcosinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370640 | stannate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370641 | cocoamphodipropionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370642 | versetamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370643 | 2,2'-dihydroxy-4,4'-dimethoxy-5,5'-disulfobenzophenone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370644 | C12-14 sec-pareth-12 sulfosuccinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370646 | laureth sulfosuccinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370648 | lauroamphodiacetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370649 | lauryl sulfosuccinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370650 | oleamido mea-sulfosuccinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370651 | oleamido mipa-sulfosuccinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370652 | C12 olefin sulfonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370653 | C12-14 olefin sulfonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370654 | C12-15 pareth-15 sulfonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370655 | C14 olefin sulfonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370656 | caseinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370657 | coco-sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370658 | cocoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370659 | dodecylbenzenesulfonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370660 | tetrachloroaurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370661 | ursolate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370662 | n-(carbonyl-methoxypolyethylene glycol 2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370663 | 2,5-dimethylbenzene-1-sulfonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370664 | acryloyldimethyltaurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370665 | acryloyldimethyltaurate-acrylamide copolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370666 | anisate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370667 | octoxynol-2 ethane sulfonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370669 | polarcrillin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370670 | dihydroxycetyl phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370671 | stearoyl lactylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370672 | hydroxymethylglycinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370673 | sesquicarbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370674 | dihydroxybenzoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370676 | Thymus citriodorus leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370677 | retinyl linoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370678 | polyquaternium-37 (10000 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370679 | sodium chloride, (22)Na | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1370680 | dexchlorpheniramine maleate 2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1370680 | dexchlorpheniramine maleate 2 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 1370680 | dexchlorpheniramine maleate 2 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1370680 | dexchlorpheniramine maleate 2 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 1370681 | Rescon-MX Reformulated Feb 2013 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1370682 | dexchlorpheniramine maleate 2 MG [Rescon-MX Reformulated Feb 2013] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1370683 | dexchlorpheniramine Oral Tablet [Rescon-MX Reformulated Feb 2013] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1370684 | Rescon-MX Reformulated Feb 2013 Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1370685 | Rescon-MX Reformulated Feb 2013 Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1370686 | dexchlorpheniramine maleate 2 MG Oral Tablet [Rescon-MX Reformulated Feb 2013] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1370686 | dexchlorpheniramine maleate 2 MG Oral Tablet [Rescon-MX Reformulated Feb 2013] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370686 | dexchlorpheniramine maleate 2 MG Oral Tablet [Rescon-MX Reformulated Feb 2013] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370688 | Suclear Bowel Prep Kit | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1370688 | Suclear Bowel Prep Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370688 | Suclear Bowel Prep Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370728 | sucrose cocoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370729 | Angelica sinensis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370731 | polyglyceryl-3 oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370732 | sodium lauroyl 1-methyl isethionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370733 | trimethylsiloxysilicate (M-Q 1.0-1.2) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370734 | eastern poison oak shoot extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370734 | eastern poison oak shoot extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370735 | A & L Laboratories Protect | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1370736 | iodine 10 MG/ML [A & L Laboratories Protect] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1370737 | iodine Topical Solution [A & L Laboratories Protect] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1370738 | A & L Laboratories Protect Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1370739 | A & L Laboratories Protect 1 % Iodine Post-milking Barrier Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1370739 | A & L Laboratories Protect 1 % Iodine Post-milking Barrier Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370739 | A & L Laboratories Protect 1 % Iodine Post-milking Barrier Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370739 | A & L Laboratories Protect 1 % Iodine Post-milking Barrier Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1370740 | A & L Laboratories 10 Mix 10 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1370741 | iodine 50 MG/ML [A & L Laboratories 10 Mix 10] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1370742 | iodine Topical Solution [A & L Laboratories 10 Mix 10] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1370743 | A & L Laboratories 10 Mix 10 Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1370744 | A & L Laboratories I0 MIX 5 % Iodine Concentrate Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370744 | A & L Laboratories I0 MIX 5 % Iodine Concentrate Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370744 | A & L Laboratories I0 MIX 5 % Iodine Concentrate Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1370744 | A & L Laboratories I0 MIX 5 % Iodine Concentrate Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1370745 | hydrocortisone probutate 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1370746 | hydrocortisone probutate 0.1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370746 | hydrocortisone probutate 0.1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1370746 | hydrocortisone probutate 0.1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370746 | hydrocortisone probutate 0.1 % Topical Cream | Designated preferred name (PT) | YES | |
| RxCUI: 1370746 | hydrocortisone probutate 0.1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1370746 | hydrocortisone probutate 0.1 % Topical Cream | Full form of descriptor (FN) | YES | |
| RxCUI: 1370747 | hydrocortisone probutate 1 MG/ML [Pandel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1370748 | Pandel 0.1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1370748 | Pandel 0.1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370748 | Pandel 0.1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1370748 | Pandel 0.1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370748 | Pandel 0.1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370749 | hydrocortisone valerate 0.002 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1370750 | hydrocortisone valerate 0.2 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1370750 | hydrocortisone valerate 0.2 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1370750 | hydrocortisone valerate 0.2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370750 | hydrocortisone valerate 0.2 % Topical Ointment | Designated preferred name (PT) | YES | |
| RxCUI: 1370750 | hydrocortisone valerate 0.2 % Topical Ointment | Full form of descriptor (FN) | YES | |
| RxCUI: 1370751 | hydrocortisone valerate 0.002 MG/MG [Westcort] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1370752 | Westcort 0.2 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1370752 | Westcort 0.2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370752 | Westcort 0.2 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1370752 | Westcort 0.2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370753 | hydrocortisone valerate 2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1370754 | hydrocortisone valerate 0.2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1370754 | hydrocortisone valerate 0.2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370754 | hydrocortisone valerate 0.2 % Topical Cream | Designated preferred name (PT) | YES | |
| RxCUI: 1370754 | hydrocortisone valerate 0.2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1370754 | hydrocortisone valerate 0.2 % Topical Cream | Full form of descriptor (FN) | YES | |
| RxCUI: 1370755 | hydrocortisone valerate 2 MG/ML [Westcort] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1370756 | Westcort 0.2 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1370756 | Westcort 0.2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1370756 | Westcort 0.2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370756 | Westcort 0.2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370757 | hydrocortisone butyrate 0.001 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1370758 | hydrocortisone butyrate 0.1 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1370758 | hydrocortisone butyrate 0.1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1370758 | hydrocortisone butyrate 0.1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370758 | hydrocortisone butyrate 0.1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370758 | hydrocortisone butyrate 0.1 % Topical Ointment | Designated preferred name (PT) | YES | |
| RxCUI: 1370758 | hydrocortisone butyrate 0.1 % Topical Ointment | Full form of descriptor (FN) | YES | |
| RxCUI: 1370759 | hydrocortisone butyrate 0.001 MG/MG [Locoid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1370760 | Locoid 0.1 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1370760 | Locoid 0.1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370760 | Locoid 0.1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1370760 | Locoid 0.1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370760 | Locoid 0.1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370761 | quince extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370762 | hydrocortisone butyrate 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1370763 | hydrocortisone butyrate 0.1 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1370763 | hydrocortisone butyrate 0.1 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370763 | hydrocortisone butyrate 0.1 % Topical Lotion | Designated preferred name (PT) | YES | |
| RxCUI: 1370763 | hydrocortisone butyrate 0.1 % Topical Lotion | Designated preferred name (PT) | YES | |
| RxCUI: 1370763 | hydrocortisone butyrate 0.1 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1370763 | hydrocortisone butyrate 0.1 % Topical Lotion | Full form of descriptor (FN) | YES | |
| RxCUI: 1370763 | hydrocortisone butyrate 0.1 % Topical Lotion | Full form of descriptor (FN) | YES | |
| RxCUI: 1370764 | hydrocortisone butyrate 1 MG/ML [Locoid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1370765 | Locoid 0.1 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1370765 | Locoid 0.1 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1370765 | Locoid 0.1 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370765 | Locoid 0.1 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370766 | barley extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370767 | hydrocortisone butyrate 0.1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1370767 | hydrocortisone butyrate 0.1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370767 | hydrocortisone butyrate 0.1 % Topical Solution | Designated preferred name (PT) | YES | |
| RxCUI: 1370767 | hydrocortisone butyrate 0.1 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1370767 | hydrocortisone butyrate 0.1 % Topical Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 1370768 | Locoid 0.1 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1370768 | Locoid 0.1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1370768 | Locoid 0.1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370768 | Locoid 0.1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370769 | Raspberry extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370769 | Raspberry extract | Designated preferred name (PT) | YES | |
| RxCUI: 1370769 | Raspberry extract | Full form of descriptor (FN) | YES | |
| RxCUI: 1370770 | hydrocortisone butyrate 0.1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1370770 | hydrocortisone butyrate 0.1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370770 | hydrocortisone butyrate 0.1 % Topical Cream | Designated preferred name (PT) | YES | |
| RxCUI: 1370770 | hydrocortisone butyrate 0.1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1370770 | hydrocortisone butyrate 0.1 % Topical Cream | Full form of descriptor (FN) | YES | |
| RxCUI: 1370771 | hydrocortisone Topical Cream [Locoid] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1370772 | Locoid Lipocream 0.1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1370772 | Locoid Lipocream 0.1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370772 | Locoid Lipocream 0.1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1370772 | Locoid Lipocream 0.1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370773 | bean extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370774 | Asian ginseng extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370776 | Swertia japonica extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370777 | bird pepper extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370778 | orange peel extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370779 | soybean germ extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370780 | hydrocortisone butyrate 0.1 % / chlorquinaldol 3 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1370780 | hydrocortisone butyrate 0.1 % / chlorquinaldol 3 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370780 | hydrocortisone butyrate 0.1 % / chlorquinaldol 3 % Topical Ointment | Designated preferred name (PT) | NO | |
| RxCUI: 1370780 | hydrocortisone butyrate 0.1 % / chlorquinaldol 3 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1370780 | hydrocortisone butyrate 0.1 % / chlorquinaldol 3 % Topical Ointment | Full form of descriptor (FN) | NO | |
| RxCUI: 1370781 | wheat gluten extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370782 | hydrocortisone butyrate 0.1 % / chlorquinaldol 3 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370782 | hydrocortisone butyrate 0.1 % / chlorquinaldol 3 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1370782 | hydrocortisone butyrate 0.1 % / chlorquinaldol 3 % Topical Cream | Designated preferred name (PT) | NO | |
| RxCUI: 1370782 | hydrocortisone butyrate 0.1 % / chlorquinaldol 3 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1370782 | hydrocortisone butyrate 0.1 % / chlorquinaldol 3 % Topical Cream | Full form of descriptor (FN) | NO | |
| RxCUI: 1370783 | seaweed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370784 | Chlorella vulgaris extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370785 | gum talha extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370786 | Viola odorata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370786 | Viola odorata whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370787 | okra extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370789 | monoethanolamine lauryl sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370790 | Astacus astacus diagnostic allergen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370790 | Astacus astacus diagnostic allergen extract | Full form of descriptor (FN) | NO | |
| RxCUI: 1370790 | Astacus astacus diagnostic allergen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370790 | Astacus astacus diagnostic allergen extract | Designated preferred name (PT) | NO | |
| RxCUI: 1370792 | Urtica urens whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370792 | Urtica urens whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370826 | benzethonium chloride 0.2 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1370826 | benzethonium chloride 0.2 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370826 | benzethonium chloride 0.2 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1370827 | polyethylene glycol 8000000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370950 | benzalkonium Cl 0.24 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370950 | benzalkonium Cl 0.24 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370950 | benzalkonium Cl 0.24 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1370950 | benzalkonium Cl 0.24 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1370951 | chloroxylenol 35 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1370952 | chloroxylenol 3.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1370952 | chloroxylenol 3.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370952 | chloroxylenol 3.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1370953 | clotrimazole Topical Oil | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1370955 | clotrimazole 4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1370956 | clotrimazole 0.4 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1370956 | clotrimazole 0.4 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370956 | clotrimazole 0.4 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1370957 | menthol 1.25 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1370957 | menthol 1.25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370957 | menthol 1.25 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1370958 | acepromazine maleate 25 MG [PROMACE] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1370959 | acepromazine Oral Tablet [PROMACE] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1370960 | PROMACE Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1370961 | PROMACE Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1370962 | PromAce Tablets 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1370962 | PromAce Tablets 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370962 | PromAce Tablets 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1370963 | dexbrompheniramine maleate 6 MG / pseudoephedrine sulfate 120 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1370963 | dexbrompheniramine maleate 6 MG / pseudoephedrine sulfate 120 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370963 | dexbrompheniramine maleate 6 MG / pseudoephedrine sulfate 120 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1370963 | dexbrompheniramine maleate 6 MG / pseudoephedrine sulfate 120 MG 12HR Extended Release Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1370963 | dexbrompheniramine maleate 6 MG / pseudoephedrine sulfate 120 MG 12HR Extended Release Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1370964 | dexbrompheniramine maleate 6 MG / pseudoephedrine sulfate 120 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1370965 | Privermectin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1370966 | ivermectin 5 MG/ML [Privermectin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1370967 | ivermectin Topical Solution [Privermectin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1370968 | Privermectin Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1370969 | Privermectin 5 MG/ML Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1370969 | Privermectin 5 MG/ML Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1370969 | Privermectin 5 MG/ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1370971 | ospemifene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370971 | ospemifene | Designated preferred name (PT) | YES | |
| RxCUI: 1370971 | ospemifene | Full form of descriptor (FN) | YES | |
| RxCUI: 1370972 | ospemifene 60 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1370973 | ospemifene Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1370974 | ospemifene Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1370975 | ospemifene Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1370976 | ospemifene 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1370976 | ospemifene 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1370977 | Osphena | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1370978 | ospemifene 60 MG [Osphena] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1370979 | ospemifene Oral Tablet [Osphena] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1370980 | Osphena Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1370981 | Osphena Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1370982 | Osphena 60 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1370982 | Osphena 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1370982 | Osphena 60 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370983 | chondroitin sulfate (chicken) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370984 | Lagerstroemia indica extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370985 | Trametes versicolor fruiting body extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370986 | Dulacia inopiflora wood extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370987 | Microcitrus australis fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370988 | puncture vine extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1370988 | puncture vine extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370989 | Morus alba extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1370990 | Planatus occidentalis bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370991 | bilberry seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1370992 | barbasco extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371 | Benomyl | Designated preferred name (PT) | NO | |
| RxCUI: 1371 | Benomyl | Full form of descriptor (FN) | NO | |
| RxCUI: 1371 | Benomyl | Designated preferred name (PT) | NO | |
| RxCUI: 1371 | Benomyl | Full form of descriptor (FN) | NO | |
| RxCUI: 1371034 | Crambe maritima leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371037 | Aloysia citrodora leaf extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1371037 | Aloysia citrodora leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371038 | Croton lechleri resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1371041 | trastuzumab emtansine | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1371041 | trastuzumab emtansine | Full form of descriptor (FN) | YES | |
| RxCUI: 1371041 | trastuzumab emtansine | Designated preferred name (PT) | YES | |
| RxCUI: 1371041 | trastuzumab emtansine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1371041 | trastuzumab emtansine | Full form of descriptor (FN) | YES | |
| RxCUI: 1371041 | trastuzumab emtansine | Designated preferred name (PT) | YES | |
| RxCUI: 1371046 | KADCYLA | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1371049 | KADCYLA Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1371051 | Amygdalin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371051 | Amygdalin | Designated preferred name (PT) | NO | |
| RxCUI: 1371051 | Amygdalin | Full form of descriptor (FN) | NO | |
| RxCUI: 1371052 | orange oil terpeneless | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1371053 | Castor canadensis scent gland secretion preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371054 | methyldiethanolamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371189 | aripiprazole 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1371189 | aripiprazole 200 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1371192 | aripiprazole 200 MG/ML [Abilify] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1371192 | aripiprazole 200 MG/ML [Abilify] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1371195 | calcium 500 MG / vitamin D3 250 UNT Oral Tablet, as calcium carbonate | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1371195 | calcium 500 MG / vitamin D3 250 UNT Oral Tablet, as calcium carbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1371195 | calcium 500 MG / vitamin D3 250 UNT Oral Tablet, as calcium carbonate | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1371196 | dextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG in 10 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1371196 | dextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG in 10 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1371196 | dextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG in 10 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1371204 | lente insulin, pork Injectable Suspension [Vetsulin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1371205 | lente insulin, pork 40 UNT/ML Injectable Suspension [Vetsulin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1371205 | lente insulin, pork 40 UNT/ML Injectable Suspension [Vetsulin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1371206 | menthol 1 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1371206 | menthol 1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1371206 | menthol 1 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1371292 | menthol 17.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1371293 | menthol 1.7307 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1371293 | menthol 1.7307 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1371293 | menthol 1.7307 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1371294 | menthol 1.7 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1371294 | menthol 1.7 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1371294 | menthol 1.7 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1371295 | benzocaine 18 % Mucous Membrane Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1371295 | benzocaine 18 % Mucous Membrane Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1371295 | benzocaine 18 % Mucous Membrane Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1371297 | Topicale Mucosal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1371298 | Topicale 18 % Mucous Membrane Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1371298 | Topicale 18 % Mucous Membrane Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1371298 | Topicale 18 % Mucous Membrane Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1371298 | Topicale 18 % Mucous Membrane Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1371299 | zinc oxide 25 % / lanolin 15.5 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1371299 | zinc oxide 25 % / lanolin 15.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1371299 | zinc oxide 25 % / lanolin 15.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1371299 | zinc oxide 25 % / lanolin 15.5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1371300 | chicory root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1371301 | Euphorbia thymifolia whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371302 | Ptychopetalum olacoides wood extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371303 | PEG-9 polydimethylsiloxyethyl dimethicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1371304 | aspartame acesulfame | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1371306 | C.I. food yellow 3 (free acid) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371307 | alpha-terpineol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371307 | alpha-terpineol | Designated preferred name (PT) | NO | |
| RxCUI: 1371307 | alpha-terpineol | Full form of descriptor (FN) | NO | |
| RxCUI: 1371308 | aluminum hydroxyide-glycine (2:1) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371310 | C12-15 alcohols | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1371311 | glycereth-7 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1371312 | Grifola frondosa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1371313 | isoxaflutole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371314 | vanillin 2,3-butanediol acetal, cis- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371315 | tartaric acid, D- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1371316 | castor oil fish whole | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1371317 | N,N-dimethylacrylamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371318 | PPG-25-laureth-25 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1371319 | regorafenib monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1371320 | menthol 1-propylene glycol carbonate, (-)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1371321 | polyquaternium-16 (N-vinylpyrrolidinone:3-methyl-1-vinylimidazolium chloride (5:5)) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1371350 | clindamycin 25 MG/ML [ANTIROBE] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1371351 | clindamycin Oral Solution [ANTIROBE] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1371352 | ANTIROBE Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1371353 | clindamycin 25 MG/ML Oral Solution [ANTIROBE] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1371353 | clindamycin 25 MG/ML Oral Solution [ANTIROBE] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1371353 | clindamycin 25 MG/ML Oral Solution [ANTIROBE] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1371354 | pramoxine hydrochloride 2.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1371355 | hydrocortisone 0.5 % / pramoxine HCl 0.25 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1371355 | hydrocortisone 0.5 % / pramoxine HCl 0.25 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1371355 | hydrocortisone 0.5 % / pramoxine HCl 0.25 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1371356 | lactic acid 1.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1371357 | salicylic acid 1.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1371358 | ketoconazole / lactate / salicylic acid Otic Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1371359 | ketoconazole / lactate / salicylic acid Otic Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1371360 | ketoconazole / lactate / salicylic acid | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1371361 | ketoconazole 0.1 % / salicylic acid 0.15 % / lactic acid 0.15 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1371361 | ketoconazole 0.1 % / salicylic acid 0.15 % / lactic acid 0.15 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1371361 | ketoconazole 0.1 % / salicylic acid 0.15 % / lactic acid 0.15 % Otic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1371361 | ketoconazole 0.1 % / salicylic acid 0.15 % / lactic acid 0.15 % Otic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1371362 | chlorhexidine / ketoconazole Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1371363 | chlorhexidine / ketoconazole Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1371364 | chlorhexidine / ketoconazole | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1371365 | chlorhexidine gluconate 2 % / ketoconazole 1 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1371365 | chlorhexidine gluconate 2 % / ketoconazole 1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1371365 | chlorhexidine gluconate 2 % / ketoconazole 1 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1371366 | tridecanol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1371366 | tridecanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1371367 | glycyrrhizin, ammoniated pentahydrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 13714 | phenylbenzimidazole sulfonic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 13714 | phenylbenzimidazole sulfonic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1371412 | coenzyme Q10 50 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1371412 | coenzyme Q10 50 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1371412 | coenzyme Q10 50 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1371443 | 2,2,2-trifluoroacetophenone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371444 | Boswellia sacra bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371445 | dodecamethylpentasiloxane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371446 | glycereth-7 trimethyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1371447 | dimethicone PEG-10 phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1371448 | 2,4-dichlorophenoxyacetic acid, sodium salt | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1371449 | 2,4-dichlorophenoxyacetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371450 | menthol 1 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1371450 | menthol 1 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1371450 | menthol 1 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1371456 | omega-3 acid ethyl esters (USP) 306 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1371457 | omega-3 acid ethyl esters 306 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1371457 | omega-3 acid ethyl esters 306 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1371457 | omega-3 acid ethyl esters 306 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1371458 | omega-3 acid ethyl esters (USP) 250 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1371459 | lutein 2.5 MG / omega-3 acid ethyl esters 250 MG / zeaxanthin 0.5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1371459 | lutein 2.5 MG / omega-3 acid ethyl esters 250 MG / zeaxanthin 0.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1371459 | lutein 2.5 MG / omega-3 acid ethyl esters 250 MG / zeaxanthin 0.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1371620 | sodium fluoride 2.3 % Toothpaste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1371620 | sodium fluoride 2.3 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1371620 | sodium fluoride 2.3 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1371819 | guaiFENesin 25 MG/mL / pseudoephedrine HCl 7.5 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1371819 | guaiFENesin 25 MG/mL / pseudoephedrine HCl 7.5 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1371819 | guaiFENesin 25 MG/mL / pseudoephedrine HCl 7.5 MG/mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1371874 | zinc citrate 0.02 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1371875 | monofluorophosphate / potassium nitrate / zinc citrate Dental Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1371876 | monofluorophosphate / potassium nitrate / zinc citrate Oral Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1371877 | monofluorophosphate / potassium nitrate / zinc citrate Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1371878 | monofluorophosphate / potassium nitrate / zinc citrate Toothpaste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1371879 | monofluorophosphate / potassium nitrate / zinc citrate Toothpaste | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1371880 | monofluorophosphate / potassium nitrate / zinc citrate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1371881 | potassium nitrate 5 % / sodium monofluorophosphate 1.14 % (0.2 % w/v fluoride ion) / zinc citrate 2 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1371881 | potassium nitrate 5 % / sodium monofluorophosphate 1.14 % (0.2 % w/v fluoride ion) / zinc citrate 2 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1371881 | potassium nitrate 5 % / sodium monofluorophosphate 1.14 % (0.2 % w/v fluoride ion) / zinc citrate 2 % Toothpaste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1371881 | potassium nitrate 5 % / sodium monofluorophosphate 1.14 % (0.2 % w/v fluoride ion) / zinc citrate 2 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1371881 | potassium nitrate 5 % / sodium monofluorophosphate 1.14 % (0.2 % w/v fluoride ion) / zinc citrate 2 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1371892 | 2-mercaptobenzothiazole 14 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1371894 | 2-mercaptobenzothiazole Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1371895 | mercaptobenzothiazole 1.4 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1371895 | mercaptobenzothiazole 1.4 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1371895 | mercaptobenzothiazole 1.4 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1371903 | Bos taurus placenta preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371904 | Bos taurus vein preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371906 | edodekin alfa | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1371907 | zinc citrate trihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1371908 | Angelica acutiloba root oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371909 | carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide; 100-200 MPA.S at 1%) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1371910 | Ipomoea purpurea seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371911 | Passiflora incarnata seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371912 | trideceth-5 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371947 | poloxamer 181 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1371948 | Drosera intermedia whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371948 | Drosera intermedia whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1371949 | Eriodictyon californicum flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371967 | edetate calcium disodium anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1371968 | glyceryl behenate-eicosadioate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1371984 | ubidecarenone 30 MG [Q-Sorb Co Q-10] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1371985 | Q-Sorb Co Q-10 30 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1371985 | Q-Sorb Co Q-10 30 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1371985 | Q-Sorb Co Q-10 30 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1371986 | iodine / lactate Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1371987 | iodine / lactate Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1371988 | iodine / lactate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1371989 | iodine 0.25 % / lactic acid 2 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1371989 | iodine 0.25 % / lactic acid 2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1371989 | iodine 0.25 % / lactic acid 2 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1371994 | synthetic camphor | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1371995 | Laminaria angustata extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371996 | Viola tricolor whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1371996 | Viola tricolor whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1371997 | Stellaria media extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1371999 | Onopordum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372 | Benorylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372 | Benorylate | Designated preferred name (PT) | NO | |
| RxCUI: 1372 | Benorylate | Full form of descriptor (FN) | NO | |
| RxCUI: 1372 | Benorylate | Designated preferred name (PT) | NO | |
| RxCUI: 1372 | Benorylate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372 | Benorylate | Full form of descriptor (FN) | NO | |
| RxCUI: 1372000 | Balsam canada | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1372000 | Balsam canada | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1372000 | Balsam canada | Designated preferred name (PT) | YES | |
| RxCUI: 1372000 | Balsam canada | Full form of descriptor (FN) | YES | |
| RxCUI: 1372000 | Balsam canada | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1372001 | Hydrangea extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372002 | blackberry flavor | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372003 | bamboo extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372004 | mint extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1372005 | dragon's blood extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372006 | slippery elm extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372006 | slippery elm extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372007 | Citrus nobilis extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1372008 | Foeniculum vulgare fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372008 | Foeniculum vulgare fruit extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372010 | Crithmum maritimum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1372010 | Crithmum maritimum whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1372011 | Acer saccharum sap extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1372013 | Gelidiella acerosa extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1372247 | geranium extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372248 | coconut extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372249 | cluster fig extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372250 | Achillea mellefolium extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1372250 | Achillea mellefolium extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1372251 | Thai galangal extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372251 | Thai galangal extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372253 | Melilotus indicus seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372253 | Melilotus indicus seed extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372255 | Hydrastis canadensis extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1372255 | Hydrastis canadensis extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1372258 | spearmint extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1372259 | Picea abies wood extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1372260 | Spanish chestnut extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372262 | snow pea extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1372263 | Glasswort extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372263 | Glasswort extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372264 | Pinus strobus extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372264 | Pinus strobus extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372265 | HYDROcodone bitartrate 5 MG / chlorpheniramine maleate 4 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1372265 | HYDROcodone bitartrate 5 MG / chlorpheniramine maleate 4 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1372265 | HYDROcodone bitartrate 5 MG / chlorpheniramine maleate 4 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372265 | HYDROcodone bitartrate 5 MG / chlorpheniramine maleate 4 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1372265 | HYDROcodone bitartrate 5 MG / chlorpheniramine maleate 4 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1372269 | iron carbonyl 18 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1372270 | iron carbonyl (as iron) 18 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1372270 | iron carbonyl (as iron) 18 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1372270 | iron carbonyl (as iron) 18 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1372271 | Chinese chestnut extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372272 | green peppercorn extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372297 | petrolatum 0.749 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1372298 | mineral oil 14 % / petrolatum 74.9 % / phenylephrine HCl 0.25 % Rectal Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1372298 | mineral oil 14 % / petrolatum 74.9 % / phenylephrine HCl 0.25 % Rectal Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1372298 | mineral oil 14 % / petrolatum 74.9 % / phenylephrine HCl 0.25 % Rectal Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1372299 | Clearasil Daily Clear Refreshing | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372300 | salicylic acid 10 MG/ML [Clearasil Daily Clear Refreshing] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1372301 | salicylic acid Medicated Pad [Clearasil Daily Clear Refreshing] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1372302 | Clearasil Daily Clear Refreshing Medicated Pad or Tape | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1372303 | Clearasil Daily Clear Refreshing Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1372304 | Clearasil Daily Clear Refreshing 1 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1372304 | Clearasil Daily Clear Refreshing 1 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372304 | Clearasil Daily Clear Refreshing 1 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372304 | Clearasil Daily Clear Refreshing 1 % Medicated Pad | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1372305 | salicylic acid Medicated Liquid Soap [Clearasil Daily Clear Refreshing] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1372306 | Clearasil Daily Clear Refreshing Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1372307 | Clearasil Daily Clear Refreshing 1 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372307 | Clearasil Daily Clear Refreshing 1 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1372307 | Clearasil Daily Clear Refreshing 1 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372307 | Clearasil Daily Clear Refreshing 1 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372307 | Clearasil Daily Clear Refreshing 1 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1372308 | human mammary gland preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372309 | C12-15 pareth-7 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1372310 | glyceryl 1-diacetyltartarate 2,3-stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1372312 | acetaminophen 160 MG / chlorpheniramine maleate 1 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1372312 | acetaminophen 160 MG / chlorpheniramine maleate 1 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1372312 | acetaminophen 160 MG / chlorpheniramine maleate 1 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1372312 | acetaminophen 160 MG / chlorpheniramine maleate 1 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1372446 | benzocaine Medicated Pad [Benz-O-Sthetic] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1372447 | Benz-O-Sthetic Medicated Pad or Tape | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1372448 | Benz-O-Sthetic Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1372449 | Benz-O-Sthetic 20 % Medicated Pad | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1372449 | Benz-O-Sthetic 20 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1372449 | Benz-O-Sthetic 20 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1372449 | Benz-O-Sthetic 20 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1372450 | camphor 10 % / menthol 5 % / methyl salicylate 15 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1372450 | camphor 10 % / menthol 5 % / methyl salicylate 15 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372450 | camphor 10 % / menthol 5 % / methyl salicylate 15 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1372451 | dextromethorphan HBr 15 MG / guaiFENesin 350 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1372451 | dextromethorphan HBr 15 MG / guaiFENesin 350 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1372451 | dextromethorphan HBr 15 MG / guaiFENesin 350 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1372451 | dextromethorphan HBr 15 MG / guaiFENesin 350 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1372451 | dextromethorphan HBr 15 MG / guaiFENesin 350 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1372458 | guaiFENesin 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1372458 | guaiFENesin 100 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1372459 | dextromethorphan HBr 5 MG / guaiFENesin 100 MG / phenylephrine HCl 2.5 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1372459 | dextromethorphan HBr 5 MG / guaiFENesin 100 MG / phenylephrine HCl 2.5 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1372459 | dextromethorphan HBr 5 MG / guaiFENesin 100 MG / phenylephrine HCl 2.5 MG in 1 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1372459 | dextromethorphan HBr 5 MG / guaiFENesin 100 MG / phenylephrine HCl 2.5 MG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1372459 | dextromethorphan HBr 5 MG / guaiFENesin 100 MG / phenylephrine HCl 2.5 MG in 1 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1372464 | capsaicin 0.025 % / menthol 10 % / methyl salicylate 25 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1372464 | capsaicin 0.025 % / menthol 10 % / methyl salicylate 25 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1372464 | capsaicin 0.025 % / menthol 10 % / methyl salicylate 25 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1372465 | acetylcholinesterase human | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372466 | Hibiscus syriacus seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372476 | Rhus chinensis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372477 | Voacanga africana seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372478 | Asarum heterotropoides whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372478 | Asarum heterotropoides whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372479 | oleoyl tyrosine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372481 | polyquaternium-37 (3000 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1372482 | ferrous gluconate 256 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1372483 | iron (as ferrous gluconate) 28 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372483 | iron (as ferrous gluconate) 28 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1372483 | iron (as ferrous gluconate) 28 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1372484 | ferrous gluconate 256 MG [Ferate] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1372485 | Ferate 256 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372485 | Ferate 256 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1372485 | Ferate 256 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372485 | Ferate 256 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1372487 | lanolin 0.5 MG/MG [Lantiseptic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1372488 | Lantiseptic 50 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1372488 | Lantiseptic 50 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1372488 | Lantiseptic 50 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1372489 | benzethonium Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1372490 | benzethonium chloride 0.2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1372490 | benzethonium chloride 0.2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1372490 | benzethonium chloride 0.2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1372524 | Tripleflex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372525 | chondroitin sulfates 400 MG / glucosamine hydrochloride 750 MG / methylsulfonylmethane 375 MG [Tripleflex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1372526 | chondroitin sulfates / glucosamine / methylsulfonylmethane Oral Tablet [Tripleflex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1372527 | Tripleflex Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1372528 | Tripleflex Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1372529 | chondroitin sulfates 400 MG / glucosamine hydrochloride 750 MG / methylsulfonylmethane 375 MG Oral Tablet [Tripleflex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1372529 | chondroitin sulfates 400 MG / glucosamine hydrochloride 750 MG / methylsulfonylmethane 375 MG Oral Tablet [Tripleflex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372538 | doxribtimine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1372538 | doxribtimine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1372539 | guanine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372540 | cytosine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372541 | Lipidro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372542 | urea 100 MG/ML [Lipidro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1372543 | urea Topical Cream [Lipidro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1372544 | Lipidro Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1372545 | Lipidro 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1372545 | Lipidro 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372545 | Lipidro 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372545 | Lipidro 10 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1372546 | triclosan 0.3 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1372546 | triclosan 0.3 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372546 | triclosan 0.3 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1372555 | Sore No More | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372556 | camphor 0.03 MG/MG / menthol 0.03 MG/MG [Sore No More] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1372557 | camphor / menthol Topical Gel [Sore No More] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1372558 | Sore No More Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1372559 | Sore No More 3 % / 3 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1372559 | Sore No More 3 % / 3 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372559 | Sore No More 3 % / 3 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1372560 | capsaicin 0.025 % / menthol 10 % / methyl salicylate 28 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1372560 | capsaicin 0.025 % / menthol 10 % / methyl salicylate 28 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1372560 | capsaicin 0.025 % / menthol 10 % / methyl salicylate 28 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1372561 | Pinus sylvestris cone extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372563 | Zingiber officinale whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1372564 | Tussilago farfara leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1372564 | Tussilago farfara leaf extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1372565 | Laminaria digitata hydrolized alginic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1372567 | polyquaternium-37 (25000 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1372568 | Bacillus polyfermenticus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372569 | Lactobacillus acidophilus 100 Million UNT Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1372569 | Lactobacillus acidophilus 100 Million UNT Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1372569 | Lactobacillus acidophilus 100 Million UNT Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1372569 | Lactobacillus acidophilus 100 Million UNT Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1372573 | linoleic acid 820 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1372574 | evening primrose oil / linoleate Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1372575 | evening primrose oil / linoleate Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1372576 | evening primrose oil / linoleate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1372577 | evening primrose oil / linoleate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1372578 | evening primrose oil 1000 MG / linoleic acid 820 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1372578 | evening primrose oil 1000 MG / linoleic acid 820 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1372631 | pigment red 5 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372632 | Alisma plantago-aquatica subsp. orientale root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372633 | Atractylodes macrocephala root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372634 | Bidens pilosa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372635 | immature Citrus aurantium fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372636 | Ilex pedunculosa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372637 | Polygonatum sibiricum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372638 | Levothyroxine sodium anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1372638 | Levothyroxine sodium anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 1372638 | Levothyroxine sodium anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 1372641 | Chinese yam extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372642 | caffeine 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1372643 | acetaminophen / caffeine / chlorpheniramine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1372644 | acetaminophen 50 MG / caffeine 1 MG / chlorpheniramine maleate 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1372644 | acetaminophen 50 MG / caffeine 1 MG / chlorpheniramine maleate 1 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1372644 | acetaminophen 50 MG / caffeine 1 MG / chlorpheniramine maleate 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372652 | dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1372652 | dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1372652 | dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1372652 | dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1372652 | dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1372658 | Naus-ease | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372659 | meclizine hydrochloride 25 MG [Naus-ease] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1372660 | meclizine Oral Tablet [Naus-ease] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1372661 | Naus-ease Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1372662 | Naus-ease Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1372663 | Naus-Ease 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1372663 | Naus-Ease 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1372663 | Naus-Ease 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372670 | amylase 2 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1372671 | protease 2 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1372672 | papain 16 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1372673 | amylase / papain / protease Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1372674 | amylase / papain / protease Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1372675 | amylase / papain / protease Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1372676 | amylase / papain / protease Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1372677 | amylase / papain / protease | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1372678 | amylase 2 UNT / papain 16 MG / protease 2 UNT Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1372680 | cinnamon bark 1000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1372681 | cinnamon bark 1000 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1372681 | cinnamon bark 1000 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1372682 | poly(N-acetyl, N-arginyl)glucosamine (50000-80000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372683 | Primalev | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372684 | Duo-Vil | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372685 | Human Mixtard | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372686 | Pancreaze | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1372687 | Corgaretic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372690 | Metatensin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372692 | Kazano | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1372693 | Ascomp | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1372694 | Marcaine with Epinephrine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1372694 | Marcaine with Epinephrine | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1372695 | Panasal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372696 | Caltrate Plus D | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1372699 | Moduretic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372700 | Anolor | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372701 | Lynox | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372702 | Palpeon | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372703 | Qsymia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1372704 | Dulera | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1372705 | Vimovo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1372706 | Jentadueto | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1372707 | Tekamlo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372708 | Fero-Grad | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372709 | Dutoprol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1372711 | Diupres | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372712 | Darvon Compound | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372713 | Stalevo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1372714 | Zodryl DEC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372715 | Monopril-HCT | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372716 | PrandiMet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372717 | Oseni | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1372718 | Aldoclor | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372719 | Moduret | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372720 | Hydropres | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372721 | Hematogen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1372722 | Uri-Sep | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372723 | Novolin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1372723 | Novolin | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1372724 | Pangestyme | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372725 | Zodryl DAC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372727 | Trifexis | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372728 | Ganda | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372730 | Kombiglyze | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1372731 | Simcor | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372732 | Tribenzor | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1372733 | Exforge HCT | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1372734 | Twynsta | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1372735 | Oreticyl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372736 | Pancron | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372738 | Janumet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1372739 | Gaviscon Chewable | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1372740 | Cyclimorph | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372741 | NovoLog Mix | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1372741 | NovoLog Mix | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1372742 | Etrafon | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372743 | Encron | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372744 | Humulin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1372744 | Humulin | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1372745 | Uridon | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372746 | Zodryl AC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372748 | Alor | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372749 | Chardonna | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372750 | Sulfoxyl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372751 | Feogen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372752 | Ferrogels | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372753 | Cortratigen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372754 | Juvisync | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372755 | Ibudone | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1372756 | Corzide | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372758 | Orabloc | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1372759 | Edarbyclor | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1372760 | Ultracaps | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372761 | Pur-In Mix | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372764 | Palcaps | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372765 | Pancrecarb MS | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372766 | Urimar | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372767 | Syntest | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372769 | Centussin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372868 | Vituz | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372869 | chlorpheniramine maleate 0.8 MG/ML / hydrocodone bitartrate 1 MG/ML [Vituz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1372869 | chlorpheniramine maleate 0.8 MG/ML / hydrocodone bitartrate 1 MG/ML [Vituz] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1372870 | chlorpheniramine / hydrocodone Oral Solution [Vituz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1372870 | chlorpheniramine / hydrocodone Oral Solution [Vituz] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1372871 | Vituz Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1372872 | Vituz Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1372873 | VITUZ 5 MG / 4 MG in 5 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1372873 | VITUZ 5 MG / 4 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1372873 | VITUZ 5 MG / 4 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372873 | VITUZ 5 MG / 4 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1372873 | VITUZ 5 MG / 4 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372873 | VITUZ 5 MG / 4 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1372873 | VITUZ 5 MG / 4 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1372874 | brilliant green 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1372875 | cod liver oil 84 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1372876 | gentian violet 65 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1372877 | brilliant green / cod liver oil / gentian violet Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1372879 | brilliant green / cod liver oil / gentian violet | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1372881 | Pad Kote | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372882 | brilliant green 10 MG/ML / cod liver oil 84 MG/ML / gentian violet 65 MG/ML [Pad Kote] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1372884 | Pad Kote Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1372887 | hydrocortisone / phenol Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1372888 | hydrocortisone / phenol Topical Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1372889 | hydrocortisone / phenol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1372890 | hydrocortisone 1 % / phenol 0.5 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1372890 | hydrocortisone 1 % / phenol 0.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1372890 | hydrocortisone 1 % / phenol 0.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372891 | lidocaine HCl 3 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1372891 | lidocaine HCl 3 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1372891 | lidocaine HCl 3 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1372892 | Unburn | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372893 | lidocaine hydrochloride 0.025 MG/MG [Unburn] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1372894 | lidocaine Topical Gel [Unburn] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1372895 | Unburn Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1372896 | unburn 2.5 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1372896 | unburn 2.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372896 | unburn 2.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1372896 | unburn 2.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372897 | lidocaine Otic Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1372898 | lidocaine Otic Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1372899 | lidocaine HCl 0.5 % Otic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1372899 | lidocaine HCl 0.5 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372899 | lidocaine HCl 0.5 % Otic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1372900 | camphor 0.0048 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1372901 | menthol 0.054 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1372902 | camphor 0.48 % / menthol 5.4 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1372902 | camphor 0.48 % / menthol 5.4 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1372902 | camphor 0.48 % / menthol 5.4 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372905 | piperonyl butoxide 4 % / pyrethrins 0.3 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1372905 | piperonyl butoxide 4 % / pyrethrins 0.3 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372905 | piperonyl butoxide 4 % / pyrethrins 0.3 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1372906 | progesterone 1380 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1372907 | progesterone 1.38 GM Vaginal Insert | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1372907 | progesterone 1.38 GM Vaginal Insert | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372907 | progesterone 1.38 GM Vaginal Insert | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1372908 | progesterone 1380 MG [Eazi-Breed CIDR] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1372909 | EAZI-BREED CIDR 1.38 GM Vaginal Insert | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1372909 | EAZI-BREED CIDR 1.38 GM Vaginal Insert | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372909 | EAZI-BREED CIDR 1.38 GM Vaginal Insert | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1372911 | undecylenic acid 37.8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1372912 | triclosan / undecylenate Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1372913 | triclosan 0.1 % / undecyclenic acid 3.78 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1372913 | triclosan 0.1 % / undecyclenic acid 3.78 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372913 | triclosan 0.1 % / undecyclenic acid 3.78 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1372914 | Ting Cream | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372915 | triclosan 1 MG/ML / undecylenic acid 37.8 MG/ML [Ting Cream] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1372916 | triclosan / undecylenate Topical Cream [Ting Cream] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1372917 | Ting Cream Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1372918 | Ting Cream (triclosan 0.1 % / undecylenic acid 3.78 % ) Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1372918 | Ting Cream (triclosan 0.1 % / undecylenic acid 3.78 % ) Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372918 | Ting Cream (triclosan 0.1 % / undecylenic acid 3.78 % ) Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1372919 | calamine 1 % / zinc oxide 18 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1372919 | calamine 1 % / zinc oxide 18 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1372919 | calamine 1 % / zinc oxide 18 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372920 | Dermasav | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1372921 | calamine 10 MG/ML / zinc oxide 180 MG/ML [Dermasav] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1372922 | calamine / zinc oxide Topical Cream [Dermasav] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1372923 | Dermasav Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1372924 | Dermasav (calamine 1 % / zinc oxide 18 % ) Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1372924 | Dermasav (calamine 1 % / zinc oxide 18 % ) Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372924 | Dermasav (calamine 1 % / zinc oxide 18 % ) Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1372924 | Dermasav (calamine 1 % / zinc oxide 18 % ) Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372925 | benzoyl peroxide 2.5 % Medicated Liquid Soap (240 ML) / salicylic acid 2 % Topical Solution (120 ML) / sulfur 5 % Topical Solution (60 ML) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372925 | benzoyl peroxide 2.5 % Medicated Liquid Soap (240 ML) / salicylic acid 2 % Topical Solution (120 ML) / sulfur 5 % Topical Solution (60 ML) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1372925 | benzoyl peroxide 2.5 % Medicated Liquid Soap (240 ML) / salicylic acid 2 % Topical Solution (120 ML) / sulfur 5 % Topical Solution (60 ML) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1372926 | dicaprylyl carbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1372927 | Gynostemma pentaphyllum top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372928 | Mexican arnica flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1372928 | Mexican arnica flower extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1372929 | disteardimonium hectorite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1372930 | Catalina preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372931 | stearalkonium hectorite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1372932 | Rhodiola crenulata root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372933 | PEG-20 sorbitan isostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372934 | sodium laureth-13 carboxylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372935 | sodium trideceth sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1372936 | brilliant green / cod liver oil / gentian violet Topical Lotion | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1372937 | brilliant green 1 % / cod liver oil 8.4 % / gentian violet 6.5 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1372937 | brilliant green 1 % / cod liver oil 8.4 % / gentian violet 6.5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372937 | brilliant green 1 % / cod liver oil 8.4 % / gentian violet 6.5 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1372938 | brilliant green / cod liver oil / gentian violet Topical Lotion [Pad Kote] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1372939 | PAD KOTE 8.4 % / 6.5 % / 1 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1372939 | PAD KOTE 8.4 % / 6.5 % / 1 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1372939 | PAD KOTE 8.4 % / 6.5 % / 1 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1372998 | cefixime Oral Capsule [Suprax] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1372999 | Suprax 400 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1372999 | Suprax 400 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1372999 | Suprax 400 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373 | Benperidol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373 | Benperidol | Designated preferred name (PT) | NO | |
| RxCUI: 1373 | Benperidol | Full form of descriptor (FN) | NO | |
| RxCUI: 1373 | Benperidol | Designated preferred name (PT) | NO | |
| RxCUI: 1373 | Benperidol | Full form of descriptor (FN) | NO | |
| RxCUI: 1373003 | Vecamyl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1373004 | mecamylamine hydrochloride 2.5 MG [Vecamyl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1373005 | mecamylamine Oral Tablet [Vecamyl] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1373006 | Vecamyl Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1373007 | Vecamyl Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1373008 | vecamyl 2.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1373008 | vecamyl 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373008 | vecamyl 2.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373009 | helium 79.6 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1373010 | oxygen 20.4 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1373011 | helium 79.6 % / oxygen 20.4 % Gas for Inhalation | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373011 | helium 79.6 % / oxygen 20.4 % Gas for Inhalation | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1373013 | cefixime 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1373014 | cefixime 500 MG in 5 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1373014 | cefixime 500 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373014 | cefixime 500 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373015 | cefixime 100 MG/ML [Suprax] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1373016 | Suprax 500 MG in 5 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1373016 | Suprax 500 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373016 | Suprax 500 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373016 | Suprax 500 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373017 | camphor 1 % / menthol 6 % / methyl salicylate 2 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1373017 | camphor 1 % / menthol 6 % / methyl salicylate 2 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1373017 | camphor 1 % / menthol 6 % / methyl salicylate 2 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373023 | iodine 3.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1373024 | iodine 0.35 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1373024 | iodine 0.35 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373024 | iodine 0.35 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1373032 | Mirabilis jalapa flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373036 | Petiveria alliacea whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373037 | Curcuma longa root oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373037 | Curcuma longa root oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1373038 | Vitis vinifera leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373039 | Rheum officinale stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373041 | polyhexamethylene biguanide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1373041 | polyhexamethylene biguanide | Designated preferred name (PT) | YES | |
| RxCUI: 1373041 | polyhexamethylene biguanide | Full form of descriptor (FN) | YES | |
| RxCUI: 1373041 | polyhexamethylene biguanide | Designated preferred name (PT) | YES | |
| RxCUI: 1373041 | polyhexamethylene biguanide | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373041 | polyhexamethylene biguanide | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373041 | polyhexamethylene biguanide | Full form of descriptor (FN) | YES | |
| RxCUI: 1373044 | dextromethorphan polistirex 6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1373045 | dextromethorphan polistirex 30 MG in 5 mL 12HR Extended Release Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1373045 | dextromethorphan polistirex 30 MG in 5 mL 12HR Extended Release Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373045 | dextromethorphan polistirex 30 MG in 5 mL 12HR Extended Release Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373045 | dextromethorphan polistirex 30 MG in 5 mL 12HR Extended Release Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373046 | dextromethorphan polistirex 6 MG/ML Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1373110 | iodoform 0.03 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1373111 | zinc oxide 0.47 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1373112 | iodoform / zinc oxide Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1373113 | iodoform / zinc oxide Topical Powder | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1373114 | iodoform / zinc oxide | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1373115 | zinc oxide 47 % / iodoform 3 % Topical Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1373115 | zinc oxide 47 % / iodoform 3 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373115 | zinc oxide 47 % / iodoform 3 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373115 | zinc oxide 47 % / iodoform 3 % Topical Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1373116 | Liqui-Vict 2X | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1373117 | pyrantel 4.54 MG/ML [Liqui-Vict 2X] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1373118 | pyrantel Oral Suspension [Liqui-Vict 2X] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1373119 | Liqui-Vict 2X Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1373120 | Liqui-Vict 2X Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1373121 | pyrantel 4.54 MG/ML Oral Suspension [Liqui-Vict 2X] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373121 | pyrantel 4.54 MG/ML Oral Suspension [Liqui-Vict 2X] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373121 | pyrantel 4.54 MG/ML Oral Suspension [Liqui-Vict 2X] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1373127 | dextromethorphan polistirex 6 MG/ML [Delsym] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1373128 | Delsym 30 MG in 5 mL 12HR Extended Release Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1373128 | Delsym 30 MG in 5 mL 12HR Extended Release Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373128 | Delsym 30 MG in 5 mL 12HR Extended Release Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373129 | dextromethorphan polistirex 6 MG/ML Extended Release Suspension [Delsym] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373129 | dextromethorphan polistirex 6 MG/ML Extended Release Suspension [Delsym] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1373130 | lidocaine HCl 4 % / menthol 1 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373130 | lidocaine HCl 4 % / menthol 1 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373130 | lidocaine HCl 4 % / menthol 1 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1373131 | Lenzapatch | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1373132 | lidocaine hydrochloride 0.04 MG/MG / menthol 0.01 MG/MG [Lenzapatch] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1373134 | Lenzapatch Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1373136 | LenzaPatch 4 % / 1 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373136 | LenzaPatch 4 % / 1 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373136 | LenzaPatch 4 % / 1 % Medicated Patch | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1373137 | lidocaine HCl 4 % / menthol 1 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373137 | lidocaine HCl 4 % / menthol 1 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1373137 | lidocaine HCl 4 % / menthol 1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373138 | Lenzagel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1373139 | lidocaine hydrochloride 0.04 MG/MG / menthol 0.01 MG/MG [Lenzagel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1373140 | lidocaine / menthol Topical Gel [Lenzagel] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1373141 | Lenzagel Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1373142 | LenzaGel 4 % / 1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373142 | LenzaGel 4 % / 1 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373142 | LenzaGel 4 % / 1 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1373143 | coal tar 18 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1373144 | coal tar 1.8 % / menthol 1.5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373144 | coal tar 1.8 % / menthol 1.5 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373144 | coal tar 1.8 % / menthol 1.5 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1373145 | Denorex Therapeutic Reformulated Mar 2013 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1373146 | coal tar 18 MG/ML / menthol 15 MG/ML [Denorex Therapeutic Reformulated Mar 2013] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1373147 | coal tar / menthol Medicated Shampoo [Denorex Therapeutic Reformulated Mar 2013] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1373148 | Denorex Therapeutic Reformulated Mar 2013 Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1373149 | Denorex Therapeutic 1.8 % / 1.5 % Medicated Shampoo, Reformulated Mar 2013 | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1373149 | Denorex Therapeutic 1.8 % / 1.5 % Medicated Shampoo, Reformulated Mar 2013 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373149 | Denorex Therapeutic 1.8 % / 1.5 % Medicated Shampoo, Reformulated Mar 2013 | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373150 | guaiac | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373152 | ethylbisiminomethylguaiacol manganese chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373153 | hydroxyethyl behenamidopropyl dimonium chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1373154 | lauryl peg-9 polydimethylsiloxyethyl dimethicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1373155 | Nelumbo nucifera root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373156 | Nelumbo nucifera whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1373157 | Polygonatum biflorum root etxract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373158 | Polygonatum odoratum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373159 | Prunus armeniaca whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373160 | Rhus chinensis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373161 | Scrophularia nodosa root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 13732 | o-Pyrocatechuate decarboxylase | Designated preferred name (PT) | NO | |
| RxCUI: 13732 | o-Pyrocatechuate decarboxylase | Full form of descriptor (FN) | NO | |
| RxCUI: 1373204 | PPG-20 methyl glucose ether distearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1373205 | Apis cerana worker secretion preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373206 | 4-tert-butylcyclohexanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1373215 | 2-butanoyloxybenzoic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1373216 | 2-butanoyloxybenzoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373217 | salicylic acid 0.1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1373217 | salicylic acid 0.1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373217 | salicylic acid 0.1 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1373218 | 3-bromocamphor, (+-)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373219 | camphor 11 % / menthol 16 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373219 | camphor 11 % / menthol 16 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373219 | camphor 11 % / menthol 16 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1373223 | petrolatum 0.438 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1373224 | petrolatum 43.8 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1373224 | petrolatum 43.8 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373224 | petrolatum 43.8 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1373224 | petrolatum 43.8 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373225 | petrolatum 0.44 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1373226 | petrolatum 44 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1373226 | petrolatum 44 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373226 | petrolatum 44 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373227 | petrolatum 0.407 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1373228 | petrolatum 40.7 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1373228 | petrolatum 40.7 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1373228 | petrolatum 40.7 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373229 | Enroflox | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1373230 | enrofloxacin 100 MG/ML [Enroflox] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1373231 | enrofloxacin Injectable Solution [Enroflox] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1373232 | Enroflox Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1373233 | Enroflox 100 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1373233 | Enroflox 100 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373233 | Enroflox 100 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1373234 | colloidal oatmeal 0.1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1373234 | colloidal oatmeal 0.1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373234 | colloidal oatmeal 0.1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1373235 | Cortisil MDX | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1373236 | hydrocortisone acetate 0.01 MG/MG [Cortisil MDX] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1373237 | hydrocortisone Topical Gel [Cortisil MDX] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1373238 | Cortisil MDX Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1373239 | CortiSil MDX 1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373239 | CortiSil MDX 1 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1373239 | CortiSil MDX 1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373239 | CortiSil MDX 1 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1373240 | ivermectin 0.8 MG/ML [Privermectin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1373241 | ivermectin Oral Solution [Privermectin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1373242 | Privermectin Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1373243 | Privermectin Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1373244 | ivermectin 0.8 MG/ML Oral Solution [Privermectin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1373244 | ivermectin 0.8 MG/ML Oral Solution [Privermectin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373245 | calamine 0.02 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1373246 | calamine / menthol / zinc oxide Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1373247 | calamine / menthol / zinc oxide Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1373248 | calamine / menthol / zinc oxide | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1373249 | calamine 2 % / menthol 0.45 % / zinc oxide 18 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1373249 | calamine 2 % / menthol 0.45 % / zinc oxide 18 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373249 | calamine 2 % / menthol 0.45 % / zinc oxide 18 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373249 | calamine 2 % / menthol 0.45 % / zinc oxide 18 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373250 | Calmafx | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1373251 | calamine 0.02 MG/MG / menthol 0.0045 MG/MG / zinc oxide 0.18 MG/MG [Calmafx] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1373252 | calamine / menthol / zinc oxide Topical Ointment [Calmafx] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1373253 | Calmafx Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1373254 | CalmaFX 2 % / 0.45 % / 18 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1373254 | CalmaFX 2 % / 0.45 % / 18 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373254 | CalmaFX 2 % / 0.45 % / 18 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373254 | CalmaFX 2 % / 0.45 % / 18 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1373322 | benzocaine 5 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1373322 | benzocaine 5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373322 | benzocaine 5 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1373323 | protease 114000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1373324 | lipase 36000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1373325 | lipase 36,000 UNT / amylase 180,000 UNT / protease 114,000 UNT Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373325 | lipase 36,000 UNT / amylase 180,000 UNT / protease 114,000 UNT Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1373325 | lipase 36,000 UNT / amylase 180,000 UNT / protease 114,000 UNT Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373325 | lipase 36,000 UNT / amylase 180,000 UNT / protease 114,000 UNT Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373326 | amylase 180000 UNT / lipase 36000 UNT / protease 114000 UNT [Creon] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1373327 | CREON 36,000 UNT / 180,000 UNT / 114,000 UNT Delayed Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1373327 | CREON 36,000 UNT / 180,000 UNT / 114,000 UNT Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373327 | CREON 36,000 UNT / 180,000 UNT / 114,000 UNT Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373327 | CREON 36,000 UNT / 180,000 UNT / 114,000 UNT Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373328 | Zenatane | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1373329 | ISOtretinoin 10 MG [Zenatane] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1373329 | ISOtretinoin 10 MG [Zenatane] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1373330 | ISOtretinoin Oral Capsule [Zenatane] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1373330 | ISOtretinoin Oral Capsule [Zenatane] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1373331 | Zenatane Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1373332 | Zenatane Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1373333 | ZENATANE 10 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1373333 | ZENATANE 10 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1373333 | ZENATANE 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373333 | ZENATANE 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373334 | ISOtretinoin 20 MG [Zenatane] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1373334 | ISOtretinoin 20 MG [Zenatane] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1373335 | ZENATANE 20 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1373335 | ZENATANE 20 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1373335 | ZENATANE 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373335 | ZENATANE 20 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373336 | ISOtretinoin 40 MG [Zenatane] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1373336 | ISOtretinoin 40 MG [Zenatane] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1373337 | ZENATANE 40 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1373337 | ZENATANE 40 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1373337 | ZENATANE 40 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373337 | ZENATANE 40 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373338 | Pro-Wormer 2 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1373339 | pyrantel 4.54 MG/ML [Pro-Wormer 2] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1373340 | pyrantel Oral Suspension [Pro-Wormer 2] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1373341 | Pro-Wormer 2 Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1373342 | Pro-Wormer 2 Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1373343 | pyrantel 4.54 MG/ML Oral Suspension [Pro-Wormer 2] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373343 | pyrantel 4.54 MG/ML Oral Suspension [Pro-Wormer 2] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373343 | pyrantel 4.54 MG/ML Oral Suspension [Pro-Wormer 2] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1373349 | copper naphthenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373350 | methyl glyoxal | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373350 | methyl glyoxal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373351 | silodrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1373352 | calcium bicarbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373353 | cetyl dimethicone 25 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1373354 | Myrothamnus flabellifolia leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373378 | dimethicone 21 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1373379 | dimethicone 2.1 % / zinc oxide 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1373379 | dimethicone 2.1 % / zinc oxide 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373379 | dimethicone 2.1 % / zinc oxide 2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1373379 | dimethicone 2.1 % / zinc oxide 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373380 | camphor 0.11 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1373381 | camphor 11 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1373381 | camphor 11 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373382 | Capsicum oleoresin 0.000625 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1373383 | Capsicum oleoresin Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1373384 | Capsicum oleoresin Topical Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1373385 | Capsicum oleoresin 0.0625 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1373385 | Capsicum oleoresin 0.0625 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373385 | Capsicum oleoresin 0.0625 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1373386 | Arthritazin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1373387 | Capsicum oleoresin 0.000625 MG/MG [Arthritazin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1373388 | Capsicum oleoresin Topical Gel [Arthritazin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1373389 | Arthritazin Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1373390 | Arthritazin EZ Pain Relief 0.0625 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373390 | Arthritazin EZ Pain Relief 0.0625 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373390 | Arthritazin EZ Pain Relief 0.0625 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373390 | Arthritazin EZ Pain Relief 0.0625 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1373390 | Arthritazin EZ Pain Relief 0.0625 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1373391 | technetium Tc 99m tilmanocept | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1373392 | copper naphthenate 375 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1373393 | copper naphthenate Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1373394 | copper naphthenate Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1373395 | copper naphthenate 37.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1373395 | copper naphthenate 37.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373395 | copper naphthenate 37.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1373396 | Pritox | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1373397 | copper naphthenate 375 MG/ML [Pritox] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1373398 | copper naphthenate Topical Solution [Pritox] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1373399 | Pritox Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1373400 | Pritox 37.5 % Water Resistant Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1373400 | Pritox 37.5 % Water Resistant Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373400 | Pritox 37.5 % Water Resistant Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1373400 | Pritox 37.5 % Water Resistant Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373444 | tamanu oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1373445 | isostearyl hydroxystearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373446 | polyquaternium-6 (15000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1373449 | peppermint oil 0.0034 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1373450 | peppermint oil Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1373451 | peppermint oil Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1373452 | peppermint oil 0.34 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1373452 | peppermint oil 0.34 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1373452 | peppermint oil 0.34 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373453 | triclocarban 3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1373454 | triclocarban 0.3 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1373454 | triclocarban 0.3 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373454 | triclocarban 0.3 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1373458 | canagliflozin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1373458 | canagliflozin | Designated preferred name (PT) | YES | |
| RxCUI: 1373458 | canagliflozin | Full form of descriptor (FN) | YES | |
| RxCUI: 1373458 | canagliflozin | Designated preferred name (PT) | YES | |
| RxCUI: 1373458 | canagliflozin | Full form of descriptor (FN) | YES | |
| RxCUI: 1373459 | canagliflozin 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1373460 | canagliflozin Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1373460 | canagliflozin Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1373460 | canagliflozin Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1373461 | canagliflozin Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1373462 | canagliflozin Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1373463 | canagliflozin 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373463 | canagliflozin 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373463 | canagliflozin 100 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1373463 | canagliflozin 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1373463 | canagliflozin 100 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1373464 | Invokana | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1373465 | canagliflozin 100 MG [Invokana] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1373466 | canagliflozin Oral Tablet [Invokana] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1373467 | Invokana Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1373468 | Invokana Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1373469 | Invokana 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1373469 | Invokana 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373469 | Invokana 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373470 | canagliflozin 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1373471 | canagliflozin 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373471 | canagliflozin 300 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1373471 | canagliflozin 300 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1373471 | canagliflozin 300 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1373472 | canagliflozin 300 MG [Invokana] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1373473 | Invokana 300 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1373473 | Invokana 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373473 | Invokana 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373478 | dimethyl fumarate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1373478 | dimethyl fumarate | Designated preferred name (PT) | YES | |
| RxCUI: 1373478 | dimethyl fumarate | Full form of descriptor (FN) | YES | |
| RxCUI: 1373478 | dimethyl fumarate | Designated preferred name (PT) | YES | |
| RxCUI: 1373478 | dimethyl fumarate | Full form of descriptor (FN) | YES | |
| RxCUI: 1373479 | dimethyl fumarate 120 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1373480 | dimethyl fumarate Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1373480 | dimethyl fumarate Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1373480 | dimethyl fumarate Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1373481 | dimethyl fumarate Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1373482 | dimethyl fumarate Delayed Release Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1373483 | dimethyl fumarate 120 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373483 | dimethyl fumarate 120 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1373483 | dimethyl fumarate 120 MG Delayed Release Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1373483 | dimethyl fumarate 120 MG Delayed Release Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1373484 | Tecfidera | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1373485 | dimethyl fumarate 120 MG [Tecfidera] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1373486 | dimethyl fumarate Delayed Release Oral Capsule [Tecfidera] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1373487 | Tecfidera Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1373488 | Tecfidera Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1373489 | Tecfidera 120 MG Delayed Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1373489 | Tecfidera 120 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373489 | Tecfidera 120 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373490 | dimethyl fumarate 240 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1373491 | dimethyl fumarate 240 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373491 | dimethyl fumarate 240 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1373491 | dimethyl fumarate 240 MG Delayed Release Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1373491 | dimethyl fumarate 240 MG Delayed Release Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1373492 | dimethyl fumarate 240 MG [Tecfidera] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1373493 | Tecfidera 240 MG Delayed Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1373493 | Tecfidera 240 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373493 | Tecfidera 240 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373493 | Tecfidera 240 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373497 | dimethyl fumarate starter dose 120 MG (14), 240 MG (46) Delayed Release Oral Capsule 60 Count Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 1373497 | dimethyl fumarate starter dose 120 MG (14), 240 MG (46) Delayed Release Oral Capsule 60 Count Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373498 | Tecfidera 30-Day Starter Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1373498 | Tecfidera 30-Day Starter Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373501 | ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373501 | ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1373502 | ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373502 | ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1373503 | Eth estra 0.01 MG (7) Oral Tablet / Eth estra-Levonorgest 0.02-0.15 MG (42) Oral Tablet / Eth estra-Levonorgest 0.025-0.15 MG (21) Oral Tablet / Eth estra-Levonorgest 0.03-0.15 MG (21) Oral Tablet 3 Month Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 1373503 | Eth estra 0.01 MG (7) Oral Tablet / Eth estra-Levonorgest 0.02-0.15 MG (42) Oral Tablet / Eth estra-Levonorgest 0.025-0.15 MG (21) Oral Tablet / Eth estra-Levonorgest 0.03-0.15 MG (21) Oral Tablet 3 Month Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373504 | Quartette 91 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1373504 | Quartette 91 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373504 | Quartette 91 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373504 | Quartette 91 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373720 | 3-O-ethyl ascorbic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373720 | 3-O-ethyl ascorbic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1373721 | 3-O-ethyl ascorbate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373722 | Citrus sinensis flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373723 | Gossypium herbaceum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373724 | methyl 3-hydroxybenzoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373725 | PEG-PPG-17-18 dimethicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373726 | polyglyceryl-3 ricinoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1373727 | retinyl retinoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373728 | Rosa canina seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1373736 | dexmedetomidine 0.004 MG/ML [Precedex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1373736 | dexmedetomidine 0.004 MG/ML [Precedex] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1373745 | nevirapine 100 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1373745 | nevirapine 100 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373745 | nevirapine 100 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373745 | nevirapine 100 MG 24HR Extended Release Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1373745 | nevirapine 100 MG 24HR Extended Release Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1373746 | nevirapine 100 MG [Viramune] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1373747 | Viramune XR 100 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1373747 | Viramune XR 100 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373747 | Viramune XR 100 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1373747 | Viramune XR 100 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1373748 | nevirapine 100 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1373749 | nevirapine 100 MG Extended Release Oral Tablet [Viramune] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1373749 | nevirapine 100 MG Extended Release Oral Tablet [Viramune] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373752 | silicon dioxide 0.178 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1373753 | sodium monofluorophosphate 0.0046 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1373754 | monofluorophosphate / silicon dioxide Dental Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1373755 | monofluorophosphate / silicon dioxide Oral Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1373756 | monofluorophosphate / silicon dioxide Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1373757 | monofluorophosphate / silicon dioxide Toothpaste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1373758 | monofluorophosphate / silicon dioxide Toothpaste | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1373759 | monofluorophosphate / silicon dioxide | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1373760 | silicon dioxide 17.8 % / sodium monofluorophosphate 0.46 % Toothpaste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1373760 | silicon dioxide 17.8 % / sodium monofluorophosphate 0.46 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1373760 | silicon dioxide 17.8 % / sodium monofluorophosphate 0.46 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373761 | sodium monofluorophosphate 0.007 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1373762 | sodium monofluorophosphate 0.7 % Toothpaste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1373762 | sodium monofluorophosphate 0.7 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1373762 | sodium monofluorophosphate 0.7 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1373895 | cocoa extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1374 | Benserazide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1374 | Benserazide | Designated preferred name (PT) | NO | |
| RxCUI: 1374 | Benserazide | Full form of descriptor (FN) | NO | |
| RxCUI: 1374 | Benserazide | Designated preferred name (PT) | NO | |
| RxCUI: 1374 | Benserazide | Full form of descriptor (FN) | NO | |
| RxCUI: 1374371 | dexamethasone acetate 8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1374371 | dexamethasone acetate 8 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1374372 | dexamethasone acetate 8 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1374372 | dexamethasone acetate 8 MG/ML Injectable Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1374372 | dexamethasone acetate 8 MG/ML Injectable Suspension | Designated preferred name (PT) | NO | |
| RxCUI: 1374372 | dexamethasone acetate 8 MG/ML Injectable Suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 1374378 | dexamethasone sodium phosphate 1 MG/ML Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1374378 | dexamethasone sodium phosphate 1 MG/ML Ophthalmic Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1374379 | docosahexaenoic acid 450 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1374380 | docosahexaenoic acid 450 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1374380 | docosahexaenoic acid 450 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1374380 | docosahexaenoic acid 450 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1374381 | clotrimazole 6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1374382 | clotrimazole 0.6 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1374382 | clotrimazole 0.6 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1374382 | clotrimazole 0.6 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1374383 | benzalkonium Cl 0.11 % / lidocaine HCl 1 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1374383 | benzalkonium Cl 0.11 % / lidocaine HCl 1 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1374383 | benzalkonium Cl 0.11 % / lidocaine HCl 1 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1374384 | dexamethasone sodium phosphate 4 MG/ML [Dexasone] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1374384 | dexamethasone sodium phosphate 4 MG/ML [Dexasone] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1374385 | dexamethasone sodium phosphate 4 MG/ML Injectable Solution [Dexasone] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1374385 | dexamethasone sodium phosphate 4 MG/ML Injectable Solution [Dexasone] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1374385 | dexamethasone sodium phosphate 4 MG/ML Injectable Solution [Dexasone] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1374386 | dexamethasone acetate 8 MG/ML [Dexasone] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1374386 | dexamethasone acetate 8 MG/ML [Dexasone] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1374387 | dexamethasone acetate 8 MG/ML Injectable Suspension [Dexasone] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1374387 | dexamethasone acetate 8 MG/ML Injectable Suspension [Dexasone] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1374387 | dexamethasone acetate 8 MG/ML Injectable Suspension [Dexasone] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1374387 | dexamethasone acetate 8 MG/ML Injectable Suspension [Dexasone] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1374388 | dexamethasone acetate 16 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1374388 | dexamethasone acetate 16 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1374389 | dexamethasone acetate 16 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1374389 | dexamethasone acetate 16 MG/ML Injectable Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1374390 | dexamethasone acetate 16 MG/ML [Dalalone] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1374390 | dexamethasone acetate 16 MG/ML [Dalalone] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1374391 | dexamethasone Injectable Suspension [Dalalone] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1374391 | dexamethasone Injectable Suspension [Dalalone] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1374392 | dexamethasone acetate 16 MG/ML Injectable Suspension [Dalalone] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1374392 | dexamethasone acetate 16 MG/ML Injectable Suspension [Dalalone] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1374392 | dexamethasone acetate 16 MG/ML Injectable Suspension [Dalalone] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1374392 | dexamethasone acetate 16 MG/ML Injectable Suspension [Dalalone] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1374395 | chlorpheniramine maleate 2.5 MG / dextromethorphan HBr 15 MG Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1374395 | chlorpheniramine maleate 2.5 MG / dextromethorphan HBr 15 MG Powder for Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1374398 | Brosimum acutifolium bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1374399 | gondoic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1374399 | gondoic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1374400 | Himatanthus lancifolius bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1374401 | Mansoa alliacea bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1374402 | Mansoa alliacea leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1374403 | Minquartia guianensis bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1374404 | Phyllanthus niruri whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1374405 | Piper aduncum leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1374406 | sorbitan dioleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1374407 | dexamethasone sodium phosphate 4 MG/ML [Dalalone] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1374407 | dexamethasone sodium phosphate 4 MG/ML [Dalalone] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1374408 | dexamethasone sodium phosphate 4 MG/ML Injectable Solution [Dalalone] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1374408 | dexamethasone sodium phosphate 4 MG/ML Injectable Solution [Dalalone] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1374408 | dexamethasone sodium phosphate 4 MG/ML Injectable Solution [Dalalone] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1374409 | dexamethasone acetate 8 MG/ML [Dalalone] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1374409 | dexamethasone acetate 8 MG/ML [Dalalone] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1374410 | dexamethasone acetate 8 MG/ML Injectable Suspension [Dalalone] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1374410 | dexamethasone acetate 8 MG/ML Injectable Suspension [Dalalone] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1374410 | dexamethasone acetate 8 MG/ML Injectable Suspension [Dalalone] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1374410 | dexamethasone acetate 8 MG/ML Injectable Suspension [Dalalone] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1374567 | tobramycin 28 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1374569 | tobramycin 28 MG Inhalation Powder Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1374569 | tobramycin 28 MG Inhalation Powder Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1374569 | tobramycin 28 MG Inhalation Powder Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1374569 | tobramycin 28 MG Inhalation Powder Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1374569 | tobramycin 28 MG Inhalation Powder Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1374570 | tobramycin 28 MG inhalation powder 224 Monthly Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 1374570 | tobramycin 28 MG inhalation powder 224 Monthly Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1374571 | tobramycin 28 MG [Tobi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1374573 | Tobi 28 MG Inhalation Powder Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1374573 | Tobi 28 MG Inhalation Powder Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1374573 | Tobi 28 MG Inhalation Powder Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1374574 | TOBI Podhaler 224 Capsule Monthly Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1374574 | TOBI Podhaler 224 Capsule Monthly Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1374574 | TOBI Podhaler 224 Capsule Monthly Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1374574 | TOBI Podhaler 224 Capsule Monthly Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1374713 | hypromellose 0.002 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1374714 | naphazoline hydrochloride 0.00025 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1374715 | polysorbate 80 0.005 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1374716 | zinc sulfate 0.0025 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1374717 | hypromellose / naphazoline / polysorbate 80 / zinc sulfate Ophthalmic Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1374718 | hypromellose 0.2 % / naphazoline HCl 0.025 % / polysorbate 80 0.5 % / zinc sulfate 0.25 % Ophthalmic Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1374718 | hypromellose 0.2 % / naphazoline HCl 0.025 % / polysorbate 80 0.5 % / zinc sulfate 0.25 % Ophthalmic Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1374718 | hypromellose 0.2 % / naphazoline HCl 0.025 % / polysorbate 80 0.5 % / zinc sulfate 0.25 % Ophthalmic Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1374718 | hypromellose 0.2 % / naphazoline HCl 0.025 % / polysorbate 80 0.5 % / zinc sulfate 0.25 % Ophthalmic Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1374724 | carboxymethylcellulose sodium 0.01 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1374725 | carboxymethylcellulose / glycerin Ophthalmic Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1374726 | carboxymethylcellulose sodium 1 % / glycerin 0.25 % Ophthalmic Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1374726 | carboxymethylcellulose sodium 1 % / glycerin 0.25 % Ophthalmic Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1374726 | carboxymethylcellulose sodium 1 % / glycerin 0.25 % Ophthalmic Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1374744 | Lactobacillus rhamnosus GG 15 Billion UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1374744 | Lactobacillus rhamnosus GG 15 Billion UNT Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1374770 | carbinoxamine maleate 4 MG in 5 mL 12HR Extended Release Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1374770 | carbinoxamine maleate 4 MG in 5 mL 12HR Extended Release Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1374770 | carbinoxamine maleate 4 MG in 5 mL 12HR Extended Release Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1374771 | Karbinal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1374772 | carbinoxamine maleate 0.8 MG/ML [Karbinal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1374773 | carbinoxamine Extended Release Suspension [Karbinal] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1374774 | Karbinal Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1374775 | Karbinal Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1374776 | Karbinal ER 4 MG in 5 mL 12HR Extended Release Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1374776 | Karbinal ER 4 MG in 5 mL 12HR Extended Release Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1374776 | Karbinal ER 4 MG in 5 mL 12HR Extended Release Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1374776 | Karbinal ER 4 MG in 5 mL 12HR Extended Release Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1374777 | carbinoxamine maleate 0.8 MG/ML Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1374778 | carbinoxamine maleate 0.8 MG/ML Extended Release Suspension [Karbinal] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1374778 | carbinoxamine maleate 0.8 MG/ML Extended Release Suspension [Karbinal] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1374779 | New-Skin Poison Ivy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1374780 | pramoxine hydrochloride 10 MG/ML [New-Skin Poison Ivy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1374781 | pramoxine Topical Lotion [New-Skin Poison Ivy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1374782 | New-Skin Poison Ivy Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1374783 | pramoxine hydrochloride 10 MG/ML Topical Lotion [New-Skin Poison Ivy] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1374783 | pramoxine hydrochloride 10 MG/ML Topical Lotion [New-Skin Poison Ivy] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1374783 | pramoxine hydrochloride 10 MG/ML Topical Lotion [New-Skin Poison Ivy] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1374784 | camphor 0.0327 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1374785 | menthol 0.0456 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1374786 | camphor 3.27 % / menthol 4.56 % / methyl salicylate 10.12 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1374786 | camphor 3.27 % / menthol 4.56 % / methyl salicylate 10.12 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1374786 | camphor 3.27 % / menthol 4.56 % / methyl salicylate 10.12 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1374787 | silicon dioxide 0.025 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1374788 | tricalcium phosphate 0.19 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1374789 | silicon dioxide / tricalcium phosphate Dental Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1374790 | silicon dioxide / tricalcium phosphate Oral Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1374791 | silicon dioxide / tricalcium phosphate Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1374792 | silicon dioxide / tricalcium phosphate Toothpaste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1374793 | silicon dioxide / tricalcium phosphate Toothpaste | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1374794 | silicon dioxide / tricalcium phosphate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1374795 | tricalcium phosphate 19 % / silicon dioxide 2.5 % Toothpaste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1374795 | tricalcium phosphate 19 % / silicon dioxide 2.5 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1374795 | tricalcium phosphate 19 % / silicon dioxide 2.5 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1374796 | Sweet-Ease | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1374797 | sucrose 240 MG/ML [Sweet-Ease] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1374798 | sucrose Oral Solution [Sweet-Ease] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1374799 | Sweet-Ease Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1374800 | Sweet-Ease Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1374801 | sucrose 240 MG/ML Oral Solution [Sweet-Ease] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1374801 | sucrose 240 MG/ML Oral Solution [Sweet-Ease] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1374802 | potassium citrate anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1374803 | succinic anhydride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1374804 | C12-15 pareth-12 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1374805 | polyisobutylene (800000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1374807 | folic acid 2000 MCG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1374807 | folic acid 2000 MCG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1374807 | folic acid 2000 MCG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1374807 | folic acid 2000 MCG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 137482 | Phytanoyl-coenzyme A alpha-hydroxylase | Designated preferred name (PT) | NO | |
| RxCUI: 137482 | Phytanoyl-coenzyme A alpha-hydroxylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 137482 | Phytanoyl-coenzyme A alpha-hydroxylase | Full form of descriptor (FN) | NO | |
| RxCUI: 137482 | Phytanoyl-coenzyme A alpha-hydroxylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1374840 | menthol 16 % / methyl salicylate 35 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1374840 | menthol 16 % / methyl salicylate 35 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1374840 | menthol 16 % / methyl salicylate 35 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1374841 | neomycin sulfate 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1374842 | neomycin sulfate 125 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1374842 | neomycin sulfate 125 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1374842 | neomycin sulfate 125 MG per 5 ML Oral Solution | Designated preferred name (PT) | YES | |
| RxCUI: 1374842 | neomycin sulfate 125 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1374842 | neomycin sulfate 125 MG per 5 ML Oral Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 1374844 | phenylephrine hydrochloride 1 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1374845 | tramiprosate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1374847 | behenyl olivate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1374848 | benzalkonium / camphor Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1374849 | benzalkonium / camphor Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1374850 | benzalkonium / camphor | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1374851 | benzalkonium chloride 0.13 % / camphor 3 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1374851 | benzalkonium chloride 0.13 % / camphor 3 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1374851 | benzalkonium chloride 0.13 % / camphor 3 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1374852 | acetyl tyrosylarginine cetyl ester | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1374852 | acetyl tyrosylarginine cetyl ester | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1374855 | docosahexaenoic acid 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1374856 | docosahexaenoate Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1374857 | docosahexaenoate Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1374858 | docosahexaenoic acid 50 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1374858 | docosahexaenoic acid 50 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1374858 | docosahexaenoic acid 50 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1374869 | vitamin B12 1000 MCG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1374869 | vitamin B12 1000 MCG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1374869 | vitamin B12 1000 MCG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1375 | Bentonite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1375 | Bentonite | Designated preferred name (PT) | YES | |
| RxCUI: 1375 | Bentonite | Full form of descriptor (FN) | YES | |
| RxCUI: 137501 | Camphorated Phenol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 137501 | Camphorated Phenol | Designated preferred name (PT) | YES | |
| RxCUI: 137501 | Camphorated Phenol | Full form of descriptor (FN) | YES | |
| RxCUI: 1375104 | dexamethasone sodium phosphate 4 MG/ML [Hexadrol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1375104 | dexamethasone sodium phosphate 4 MG/ML [Hexadrol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1375105 | dexamethasone Injectable Solution [Hexadrol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1375105 | dexamethasone Injectable Solution [Hexadrol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1375106 | Hexadrol Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1375107 | dexamethasone sodium phosphate 4 MG/ML Injectable Solution [Hexadrol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1375107 | dexamethasone sodium phosphate 4 MG/ML Injectable Solution [Hexadrol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1375107 | dexamethasone sodium phosphate 4 MG/ML Injectable Solution [Hexadrol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1375107 | dexamethasone sodium phosphate 4 MG/ML Injectable Solution [Hexadrol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1375110 | carbetapentane citrate 4 MG/mL / dexchlorpheniramine maleate 0.2 MG/mL / phenylephrine hydrochloride 2 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1375110 | carbetapentane citrate 4 MG/mL / dexchlorpheniramine maleate 0.2 MG/mL / phenylephrine hydrochloride 2 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1375114 | dexamethasone sodium phosphate 4 MG/ML [Decadron] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1375114 | dexamethasone sodium phosphate 4 MG/ML [Decadron] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1375115 | dexamethasone sodium phosphate 4 MG/ML Injectable Solution [Decadron] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1375115 | dexamethasone sodium phosphate 4 MG/ML Injectable Solution [Decadron] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1375115 | dexamethasone sodium phosphate 4 MG/ML Injectable Solution [Decadron] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1375115 | dexamethasone sodium phosphate 4 MG/ML Injectable Solution [Decadron] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1375123 | carbetapentane citrate 4 MG/mL / pseudoephedrine hydrochloride 6 MG/mL / pyrilamine maleate 1.5 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1375123 | carbetapentane citrate 4 MG/mL / pseudoephedrine hydrochloride 6 MG/mL / pyrilamine maleate 1.5 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1375124 | carbetapentane citrate 4 MG/ML / pseudoephedrine hydrochloride 6 MG/ML / pyrilamine maleate 1.5 MG/ML [Corzall Plus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1375125 | carbetapentane citrate 4 MG/ML / pseudoephedrine hydrochloride 6 MG/ML / pyrilamine maleate 1.5 MG/ML Oral Solution [Corzall Plus] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1375125 | carbetapentane citrate 4 MG/ML / pseudoephedrine hydrochloride 6 MG/ML / pyrilamine maleate 1.5 MG/ML Oral Solution [Corzall Plus] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1375126 | carbetapentane citrate 4 MG/ML / pseudoephedrine hydrochloride 6 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1375378 | ascorbic acid / iron carbonyl Delayed Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1375379 | iron carbonyl (as iron) 65 MG / ascorbic acid 125 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1375379 | iron carbonyl (as iron) 65 MG / ascorbic acid 125 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1375379 | iron carbonyl (as iron) 65 MG / ascorbic acid 125 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1375379 | iron carbonyl (as iron) 65 MG / ascorbic acid 125 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1375412 | bupivacaine hydrochloride anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1375412 | bupivacaine hydrochloride anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 1375412 | bupivacaine hydrochloride anhydrous | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1375412 | bupivacaine hydrochloride anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 1375414 | C20-40 pareth-3 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1375415 | castor fiber scent gland secretion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1375916 | bromfenac 0.7 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1375917 | bromfenac 0.07 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1375917 | bromfenac 0.07 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1375917 | bromfenac 0.07 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1375917 | bromfenac 0.07 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1375918 | Prolensa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1375919 | bromfenac 0.7 MG/ML [Prolensa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1375920 | bromfenac Ophthalmic Solution [Prolensa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1375921 | Prolensa Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1375922 | PROLENSA 0.07 % Ophthalmic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1375922 | PROLENSA 0.07 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1375922 | PROLENSA 0.07 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1375922 | PROLENSA 0.07 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1375923 | arsenic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1375924 | arsenate ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1375924 | arsenate ion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1375932 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1375932 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1375932 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1375932 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1375932 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1375932 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1375932 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1375932 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1375932 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1375932 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1375932 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1375932 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1375932 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1375942 | Bifidobacterium infantis 1.5 Billion UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1375942 | Bifidobacterium infantis 1.5 Billion UNT Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1375942 | Bifidobacterium infantis 1.5 Billion UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1375942 | Bifidobacterium infantis 1.5 Billion UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1375944 | Doxylamine- and pyridoxine-containing product in oral dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1375944 | Doxylamine- and pyridoxine-containing product in oral dose form | Designated preferred name (PT) | YES | |
| RxCUI: 1375944 | Doxylamine- and pyridoxine-containing product in oral dose form | Full form of descriptor (FN) | YES | |
| RxCUI: 1375945 | doxylamine / pyridoxine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1375946 | doxylamine / pyridoxine Delayed Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1375947 | Product containing doxylamine and pyridoxine (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1375947 | Product containing doxylamine and pyridoxine (medicinal product) | Designated preferred name (PT) | YES | |
| RxCUI: 1375947 | Product containing doxylamine and pyridoxine (medicinal product) | Full form of descriptor (FN) | YES | |
| RxCUI: 1375948 | doxylamine succinate 10 MG / pyridoxine HCl 10 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1375948 | doxylamine succinate 10 MG / pyridoxine HCl 10 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1375948 | doxylamine succinate 10 MG / pyridoxine HCl 10 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1375948 | doxylamine succinate 10 MG / pyridoxine HCl 10 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1375949 | Diclegis | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1375950 | doxylamine succinate 10 MG / pyridoxine hydrochloride 10 MG [Diclegis] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1375951 | doxylamine / pyridoxine Delayed Release Oral Tablet [Diclegis] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1375952 | Diclegis Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1375953 | Diclegis Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1375954 | Diclegis 10 MG / 10 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1375954 | Diclegis 10 MG / 10 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1375954 | Diclegis 10 MG / 10 MG Delayed Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1375954 | Diclegis 10 MG / 10 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1375954 | Diclegis 10 MG / 10 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1375955 | cholecalciferol 6.67 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1375956 | cholecalciferol / glucose Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1375957 | cholecalciferol / glucose Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1375958 | cholecalciferol / glucose Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1375959 | cholecalciferol / glucose | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1375960 | cholecalciferol 6.67 UNT/mL / glucose 250 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1375960 | cholecalciferol 6.67 UNT/mL / glucose 250 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1375960 | cholecalciferol 6.67 UNT/mL / glucose 250 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1375977 | capsaicin / menthol / methyl salicylate Topical Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1375978 | capsaicin 0.25 % / menthol 10 % / menthyl salicylate 28 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1375978 | capsaicin 0.25 % / menthol 10 % / menthyl salicylate 28 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1375978 | capsaicin 0.25 % / menthol 10 % / menthyl salicylate 28 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1375979 | zinc acetate 2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1375980 | zinc acetate Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1375981 | zinc acetate 0.2 % topical cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1375981 | zinc acetate 0.2 % topical cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1375981 | zinc acetate 0.2 % topical cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1375982 | cholecalciferol / glucose Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1375983 | cholecalciferol / glucose Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1375984 | cholecalciferol / glucose Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1375985 | dextrose 4 GM / cholecalciferol 10 MCG (400 UNT) Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1375985 | dextrose 4 GM / cholecalciferol 10 MCG (400 UNT) Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1375985 | dextrose 4 GM / cholecalciferol 10 MCG (400 UNT) Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1375985 | dextrose 4 GM / cholecalciferol 10 MCG (400 UNT) Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376002 | folic acid / succinic acid Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1376003 | folic acid / succinic acid Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1376004 | folic acid / succinic acid Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1376005 | folic acid / succinic acid | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1376006 | folic acid 400 MCG / succinic acid 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376006 | folic acid 400 MCG / succinic acid 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1376006 | folic acid 400 MCG / succinic acid 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1376006 | folic acid 400 MCG / succinic acid 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376054 | dexamethasone sodium phosphate 0.0005 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1376054 | dexamethasone sodium phosphate 0.0005 MG/MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1376055 | dexamethasone sodium phosphate 0.0005 MG/MG Ophthalmic Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1376055 | dexamethasone sodium phosphate 0.0005 MG/MG Ophthalmic Ointment | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1376056 | dexamethasone sodium phosphate 0.0005 MG/MG [Decadron] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1376056 | dexamethasone sodium phosphate 0.0005 MG/MG [Decadron] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1376057 | dexamethasone Ophthalmic Ointment [Decadron] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1376057 | dexamethasone Ophthalmic Ointment [Decadron] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1376058 | Decadron Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1376059 | dexamethasone sodium phosphate 0.0005 MG/MG Ophthalmic Ointment [Decadron] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376059 | dexamethasone sodium phosphate 0.0005 MG/MG Ophthalmic Ointment [Decadron] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376059 | dexamethasone sodium phosphate 0.0005 MG/MG Ophthalmic Ointment [Decadron] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376059 | dexamethasone sodium phosphate 0.0005 MG/MG Ophthalmic Ointment [Decadron] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1376059 | dexamethasone sodium phosphate 0.0005 MG/MG Ophthalmic Ointment [Decadron] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1376060 | dexamethasone sodium phosphate 1 MG/ML [Decadron] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1376060 | dexamethasone sodium phosphate 1 MG/ML [Decadron] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1376061 | dexamethasone Ophthalmic Solution [Decadron] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1376061 | dexamethasone Ophthalmic Solution [Decadron] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1376062 | dexamethasone sodium phosphate 1 MG/ML Ophthalmic Solution [Decadron] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376062 | dexamethasone sodium phosphate 1 MG/ML Ophthalmic Solution [Decadron] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376062 | dexamethasone sodium phosphate 1 MG/ML Ophthalmic Solution [Decadron] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376062 | dexamethasone sodium phosphate 1 MG/ML Ophthalmic Solution [Decadron] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1376062 | dexamethasone sodium phosphate 1 MG/ML Ophthalmic Solution [Decadron] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1376063 | dexamethasone sodium phosphate 1 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1376063 | dexamethasone sodium phosphate 1 MG/ML Topical Cream | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1376064 | dexamethasone Topical Cream [Decadron] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1376064 | dexamethasone Topical Cream [Decadron] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1376065 | Decadron Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1376066 | dexamethasone sodium phosphate 1 MG/ML Topical Cream [Decadron] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376066 | dexamethasone sodium phosphate 1 MG/ML Topical Cream [Decadron] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376066 | dexamethasone sodium phosphate 1 MG/ML Topical Cream [Decadron] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376066 | dexamethasone sodium phosphate 1 MG/ML Topical Cream [Decadron] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1376066 | dexamethasone sodium phosphate 1 MG/ML Topical Cream [Decadron] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1376067 | dexamethasone sodium phosphate 24 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1376067 | dexamethasone sodium phosphate 24 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1376068 | dexamethasone sodium phosphate 24 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1376068 | dexamethasone sodium phosphate 24 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1376069 | dexamethasone sodium phosphate 24 MG/ML [Decadron] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1376069 | dexamethasone sodium phosphate 24 MG/ML [Decadron] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1376070 | dexamethasone sodium phosphate 24 MG/ML Injectable Solution [Decadron] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376070 | dexamethasone sodium phosphate 24 MG/ML Injectable Solution [Decadron] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376070 | dexamethasone sodium phosphate 24 MG/ML Injectable Solution [Decadron] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1376070 | dexamethasone sodium phosphate 24 MG/ML Injectable Solution [Decadron] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1376071 | Simply Saline Wound Wash | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1376072 | benzethonium chloride 1.3 MG/ML [Simply Saline Wound Wash] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1376073 | benzethonium Topical Spray [Simply Saline Wound Wash] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1376074 | Simply Saline Wound Wash Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1376075 | Simply Saline Wound Wash 0.13 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1376075 | Simply Saline Wound Wash 0.13 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1376075 | Simply Saline Wound Wash 0.13 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376075 | Simply Saline Wound Wash 0.13 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376076 | plant stanol ester 450 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1376076 | plant stanol ester 450 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1376077 | lactic acid 57 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1376078 | lactic acid 5.7 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1376078 | lactic acid 5.7 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376078 | lactic acid 5.7 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1376083 | cabazitaxel 40 MG/ML [Jevtana] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1376084 | JEVTANA 60 MG in 1.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1376084 | JEVTANA 60 MG in 1.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1376084 | JEVTANA 60 MG in 1.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1376084 | JEVTANA 60 MG in 1.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1376085 | dimethicone / zinc oxide Topical Lotion | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1376086 | dimethicone 2.3 % / zinc oxide 2 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1376086 | dimethicone 2.3 % / zinc oxide 2 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376086 | dimethicone 2.3 % / zinc oxide 2 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1376086 | dimethicone 2.3 % / zinc oxide 2 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376087 | Cestrum latifolium leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1376088 | Olea europaea bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1376089 | Salicylic Acid 5 MG/ML Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1376089 | Salicylic Acid 5 MG/ML Paste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1376090 | Clearskin Pore Penetrating Black Mineral Mask | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1376091 | salicylic acid 5 MG/ML [Clearskin Pore Penetrating Black Mineral Mask] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1376092 | salicylic acid Paste [Clearskin Pore Penetrating Black Mineral Mask] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1376093 | Clearskin Pore Penetrating Black Mineral Mask Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1376094 | Clearskin Pore Penetrating Black Mineral Mask 5 % Topical Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1376094 | Clearskin Pore Penetrating Black Mineral Mask 5 % Topical Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376094 | Clearskin Pore Penetrating Black Mineral Mask 5 % Topical Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376094 | Clearskin Pore Penetrating Black Mineral Mask 5 % Topical Paste | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1376095 | dicetyldimonium chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1376096 | ethyl linalool | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1376097 | trimethylbenzenepropanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1376098 | cetyl PEG- PPG-10- 1 dimethicone (HLB 3) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1376099 | glyceryl tribehenate- isostearate- eicosandioate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1376147 | caprylic-capric-linoleic triglyceride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1376148 | gamma-undecalactone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1376149 | alpha-tocopherylquinone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1376150 | hydroxyethyl cellulose (40 MPA.S at 2%) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1376151 | lingonberry seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1376152 | phenylisohexanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1376153 | tetrahydrobisdemethoxydiferuloylmethane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1376154 | tetrahydrodemethoxydiferuloylmethane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1376155 | potassium triiodide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1376156 | riboprine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1376206 | magnesium hydroxide 105 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1376207 | aluminum hydroxide 160 MG / magnesium hydroxide 105 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1376207 | aluminum hydroxide 160 MG / magnesium hydroxide 105 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1376210 | salicylic acid 2 % Topical Gel (0.25 FL OZ) / salicylic acid 1 % Medicated Liquid Soap (3 FL OZ) / salicylic acid 1 % Topical Cream (15 GM) / Salicylic Acid 0.5 % Medicated Pad (30) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376210 | salicylic acid 2 % Topical Gel (0.25 FL OZ) / salicylic acid 1 % Medicated Liquid Soap (3 FL OZ) / salicylic acid 1 % Topical Cream (15 GM) / Salicylic Acid 0.5 % Medicated Pad (30) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1376210 | salicylic acid 2 % Topical Gel (0.25 FL OZ) / salicylic acid 1 % Medicated Liquid Soap (3 FL OZ) / salicylic acid 1 % Topical Cream (15 GM) / Salicylic Acid 0.5 % Medicated Pad (30) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1376211 | Coptis chinensis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1376212 | Garcinia indica fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1376213 | safflower bud extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1376213 | safflower bud extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1376214 | Corydalis ambigua tuber extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1376215 | Sambucus canadensis flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1376249 | neomycin sulfate 25 MG/ML [Mycifradin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1376250 | neomycin sulfate 25 MG/ML Oral Solution [Mycifradin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376250 | neomycin sulfate 25 MG/ML Oral Solution [Mycifradin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376250 | neomycin sulfate 25 MG/ML Oral Solution [Mycifradin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1376335 | prednisolone acetate 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1376335 | prednisolone acetate 10 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1376336 | prednisoLONE acetate 1 % Ophthalmic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1376336 | prednisoLONE acetate 1 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1376336 | prednisoLONE acetate 1 % Ophthalmic Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1376336 | prednisoLONE acetate 1 % Ophthalmic Suspension | Designated preferred name (PT) | YES | |
| RxCUI: 1376336 | prednisoLONE acetate 1 % Ophthalmic Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1376336 | prednisoLONE acetate 1 % Ophthalmic Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1376336 | prednisoLONE acetate 1 % Ophthalmic Suspension | Full form of descriptor (FN) | YES | |
| RxCUI: 1376337 | desoximetasone Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1376338 | desoximetasone 0.25 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1376338 | desoximetasone 0.25 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1376338 | desoximetasone 0.25 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1376339 | desoximetasone Topical Spray [Topicort] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1376340 | Topicort 0.25 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1376340 | Topicort 0.25 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1376340 | Topicort 0.25 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1376340 | Topicort 0.25 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1376341 | 3-(3,4-methylenedioxyphenyl)-2-methylpropanal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1376342 | apocarotenal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1376343 | cyclamen aldehyde | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1376344 | hydroxyethyl cellulose (6500 MPA.S at 2%) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1376345 | hypromellose acetate succinate 06081224 (3 MM2-S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1376346 | Lavandula angustifolia whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1376347 | Olea europaea whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1376348 | Rosmarinus officinalis flowering top oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1376349 | Thymus vulgaris whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1376379 | benzalkonium chloride 1.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1376380 | benzalkonium Cl 0.14 % / benzocaine 5 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1376380 | benzalkonium Cl 0.14 % / benzocaine 5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1376380 | benzalkonium Cl 0.14 % / benzocaine 5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376384 | D-Thrush | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1376385 | copper naphthenate 375 MG/ML [D-Thrush] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1376386 | copper naphthenate Topical Solution [D-Thrush] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1376387 | D-Thrush Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1376388 | D-THRUSH Water Resistant 37.5 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1376388 | D-THRUSH Water Resistant 37.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376388 | D-THRUSH Water Resistant 37.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376388 | D-THRUSH Water Resistant 37.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1376389 | Loris | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1376391 | povidone-iodine Topical Solution [Loris] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1376392 | Loris Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1376394 | povidone-iodine 100 MG/ML [Loris] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1376395 | LORIS 10 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1376395 | LORIS 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376395 | LORIS 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376395 | LORIS 10 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1376425 | ThrushTox | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1376426 | copper naphthenate 375 MG/ML [ThrushTox] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1376427 | copper naphthenate Topical Solution [ThrushTox] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1376428 | ThrushTox Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1376429 | THRUSHTOX Water Resistant 37.5 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1376429 | THRUSHTOX Water Resistant 37.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376429 | THRUSHTOX Water Resistant 37.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376429 | THRUSHTOX Water Resistant 37.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1376436 | triamcinolone acetonide 1.5 MG [Cortalone] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1376437 | triamcinolone Oral Tablet [Cortalone] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1376438 | Cortalone Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1376439 | Cortalone Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1376440 | CORTALONE 1.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1376440 | CORTALONE 1.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376440 | CORTALONE 1.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1376446 | Barrier-Dyne | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1376447 | iodine 10 MG/ML [Barrier-Dyne] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1376448 | iodine Topical Solution [Barrier-Dyne] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1376449 | Barrier-Dyne Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1376450 | Barrier-Dyne 10, 1 % Barrier Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376450 | Barrier-Dyne 10, 1 % Barrier Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1376450 | Barrier-Dyne 10, 1 % Barrier Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376450 | Barrier-Dyne 10, 1 % Barrier Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1376451 | C9-11 pareth-6 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1376452 | hydroxyethyl cellulose (1800 MPA.S at 2%) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1376473 | VetStarch | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1376474 | hydroxyethyl starch 130-0.4 60 MG/ML [VetStarch] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1376475 | hydroxyethyl starch 130-0.4 Injectable Solution [VetStarch] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1376476 | VetStarch Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1376477 | VetStarch 60 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1376477 | VetStarch 60 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1376477 | VetStarch 60 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376479 | Equi-Thrush | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1376480 | copper naphthenate 375 MG/ML [Equi-Thrush] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1376481 | copper naphthenate Topical Solution [Equi-Thrush] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1376482 | Equi-Thrush Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1376483 | copper naphthenate 375 MG/ML Topical Solution [Equi-Thrush] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1376483 | copper naphthenate 375 MG/ML Topical Solution [Equi-Thrush] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376483 | copper naphthenate 375 MG/ML Topical Solution [Equi-Thrush] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376485 | copper naphthenate 375 MG/ML [KOPERTOX] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1376486 | copper naphthenate Topical Solution [KOPERTOX] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1376488 | KOPERTOX Water Resistant 37.5 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1376488 | KOPERTOX Water Resistant 37.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376488 | KOPERTOX Water Resistant 37.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376488 | KOPERTOX Water Resistant 37.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1376489 | Linco-Jec | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1376490 | lincomycin 300 MG/ML [Linco-Jec] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1376491 | lincomycin Injectable Solution [Linco-Jec] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1376492 | Linco-Jec Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1376493 | lincomycin 300 MG/ML Injectable Solution [Linco-Jec] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376493 | lincomycin 300 MG/ML Injectable Solution [Linco-Jec] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1376494 | menthol 8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1376495 | methyl salicylate 30 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1376496 | menthol 0.8 % / methyl salicylate 3 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1376496 | menthol 0.8 % / methyl salicylate 3 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1376496 | menthol 0.8 % / methyl salicylate 3 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1376497 | menthol 0.019 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1376498 | methyl salicylate 0.137 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1376499 | menthol 1.9 % / methyl salicylate 13.7 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1376499 | menthol 1.9 % / methyl salicylate 13.7 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1376499 | menthol 1.9 % / methyl salicylate 13.7 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1376500 | Panax pseudoginseng root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1376501 | Huperzia serrata extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 137665 | Product containing voglibose (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 137665 | Product containing voglibose (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 137665 | Product containing voglibose (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 137665 | Product containing voglibose (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 137732 | chromium nicotinic acid complex | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1378 | Benzalkonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1378 | Benzalkonium | Designated preferred name (PT) | YES | |
| RxCUI: 1378 | Benzalkonium | Full form of descriptor (FN) | YES | |
| RxCUI: 1378 | Benzalkonium | Designated preferred name (PT) | YES | |
| RxCUI: 1378 | Benzalkonium | Full form of descriptor (FN) | YES | |
| RxCUI: 1379 | Benzalkonium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1379 | Benzalkonium chloride | Designated preferred name (PT) | YES | |
| RxCUI: 1379 | Benzalkonium chloride | Full form of descriptor (FN) | YES | |
| RxCUI: 137939 | silver acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1379968 | Product containing thyroid hormone (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 1379968 | Product containing thyroid hormone (medicinal product) | Designated preferred name (PT) | NO |